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II.	Abstract		Multi-drug	 resistant	 bacteria	 have	 become	 a	 real	 threat	 to	 public	 health	worldwide.	 Gram-negative	 bacteria,	 in	 particular,	 have	 shown	 high	 level	 of	antibiotic	 resistance	 due	 to	 the	 presence	 of	 an	 additional	membrane,	 known	 as	outer-membrane	 (OM),	 that	 acts	 as	 an	 extra	 barrier.	Most	 antibiotics	 enter	 the	cells	via	a	particular	class	of	outer-membrane	proteins	(OMPs)	known	as	porins.	Porins	 are	 β-barrel	 channels	 that	 allow	 the	 passive	 diffusion	 of	 hydrophobic	compounds.	The	porins	are	known	to	select	against	molecules	on	the	basis	of	size	and	 charge.	 When	 exposed	 to	 antibiotics,	 bacteria	 can	 modify	 the	 OM	permeability	 by	 altering	 their	 porins	 profile.	 Mutations	 affecting	 the	 size	 and	conductivity	 of	 the	 pore	 channel,	 and	 modification	 of	 the	 level	 of	 porins	expression	are	 just	 few	examples	of	how	the	bacteria	can	decrease	 the	 influx	of	antibiotics.			In	 order	 to	 better	 understand	 their	 interaction	 with	 antibiotics,	 this	 thesis	presents	 structural	 and	 functional	 studies	 on	 porins	 from	 pathogenic	 bacteria.	The	structure	of	the	natively	expressed	major	outer-membrane	protein	(MOMP)	from	Campylobacter	 jejuni	 was	 determined,	 reveling	 the	 presence	 of	 a	 calcium-binding	site	inside	the	channel.	Electrophysiology	and	 in	silico	modeling	analysis	have	 shown	 to	 be	 important	 for	 the	 stability	 and	 the	 function	 of	 the	 protein.	Omp50	from	C.	jejuni	was	expressed	in	E.	coli	and	its	tyrosine	kinase	activity	was	analyzed	 in	 vitro.	 Finally,	 the	 structures	 of	 the	 two	 major	 porins	 from	
Enterobacter	aerogens	were	determined	and	compared	to	their	orthologs	within	the	Enterobacteriaceae	family.	Further,	a	liposome-swelling	assay	(LSA)	was	used	
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	Bacteria,	like	all	living	cells,	possess	an	envelope	that	allows	them	to	protect	the	cytoplasmic	 contents	 from	 the	 surrounding	 environment.	 In	 addition	 to	 this	membrane,	Gram-positive	 and	Gram-negative	 bacteria	 [1]	 have	 a	 peptidoglycan	layer.	Gram-negative	bacteria	possess	a	further	additional	‘outer’	membrane	that	has	 a	 distinctive	 composition.	 This	 introduction	 will	 focus	 on	 the	 membrane	structure	 and	 composition	 of	 the	 Gram-negative	 bacteria,	 with	 a	 particular	interest	in	the	outer-membrane.			Gram-negative	bacteria	are	composed	of	two	chemically	distinct	membranes,	the	inner	 membrane	 (IM)	 (separates	 cytoplasm	 from	 periplasm),	 and	 the	 outer-membrane	(OM)	(separates	periplasm	from	extra-cellular	space).	The	periplasm,	is	an	aqueous	compartment	containing	a	 layer	of	peptidoglycan.	While	 the	IM	is	composed	 of	 a	 bilayer	 of	 phospholipids	 (with	 ethanolamine	 and	 phosphatidyl	glycerol	 being	 the	most	 abundant	 phospholipids),	 the	 composition	 of	 the	OM	 is	more	complex.	The	inner	leaflet	of	the	OM	(facing	the	periplasm)	shows	a	similar	composition	 to	 the	 IM,	 whereas	 the	 outer	 leaflet	 is	 mainly	 composed	 of	glycolipids,	which	form	the	lipopolysaccharide	(LPS)	[2].		The	LPS	is	essential	for	the	Gram-negative	survival	and	is	therefore	ubiquitously	produced	in	all	species.	The	structure	of	the	LPS	has	been	extensively	studied	in	the	last	few	decades,	and	it	has	now	been	well	characterized.	The	LPS	is	organized	
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	The	outer-membrane	 is	embedded	with	proteins	 that	display	a	characteristic	β-barrel	 arrangement.	 To	 date,	 many	 outer-membrane	 protein	 (OMP)	 structures	have	been	solved	by	X-ray	crystallography	and	almost	all	of	these	share	common	features	 that	 can	 be	 summarized	 as	 follows:	 i)	 they	 are	made	 of	 antiparallel	 β-strands	connected	to	each	other	(the	number	of	the	β-strands	differs	amongst	the	OMPs,	 ranging	 from	 a	minimum	 of	 8	 to	 a	maximum	 of	 26),	 (Wza	was	 the	 first	exception	to	this	rule	[9])	ii)	both	the	N-	and	the	C-terminus	face	the	periplasmic	space,	iii)	the	β-strands	are	connected	by	longs	loops	(L)	facing	the	extra-cellular	space	and	short	turns	(T)	facing	the	periplasmic	space,	iv)	the	loops	represent	the	most	variable	part	of	the	barrel,	vi)	in	most	(but	not	in	all)	the	OMPs	the	L3	folds	back	 inside	 the	 channel	 to	 form	 the	 so-called	 constriction	 zone	 or	 eyelet,	 vii)	when	 trimerized,	 a	 non-polar	 core	 is	 formed	 along	 the	 threefold	 axis,	 viii)	 the	external	surface	of	 the	barrel	 (embedded	 in	 the	 lipid	bilayer)	consists	mainly	of	hydrophobic,	uncharged	amino-acids[10],[11].		The	OMPs	play	multiple	roles	that	are	essential	for	the	viability	of	bacteria,	they	form	 channels	 for	 the	 uptake	 of	 nutrients,	maintain	 the	 bilayer	 asymmetry,	 are	involved	in	cellular	adhesion,	and	can	also	act	as	enzyme	(e.g.	protease)	[12],[13].		
1.1.3	Passive	transport	through	the	OM:	Porins	
	Porin	 transporters	exemplified	by	OmpC	are	water	 filled	 channels	embedded	 in	the	OM,	 allowing	 the	passive	diffusion	 of	 polar	molecules	 [14].	 Like	most	 other	
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Figure	1.2:	Cartoon	representation	of	OmpC	from	E.	coli.	(A)	Extracellular	view	of	OmpC	trimer	(B)	Side	view	of	OmpC	monomer.	Extracellular	loops	are	indicated	with	L	and	periplasmic	turns	with	T.	(PDB	code:	2J1n)		Non-specific	(also	known	as	general)	and	specific	porins	are	differentiated	based	on	 the	 level	 of	 specificity	 shown	 for	 their	 substrates.	 Normally	 16-β-stranded,	general	 porins	 allow	 permeation	 of	 substances	 with	 a	 MW	 lower	 than	 600	 Da	with	a	slight	selectivity	for	cations.	Cation-selectivity	in	general	porins	–	such	as	in	 OmpC	 [25]	 and	 OmpF	 [26]	 from	 E.	 coli,	 and	 in	OmpK36	 and	 OmpK35	 from	

















































1.1.4	Active	transport	through	OM:	TonB-dependent	transporters		TonB-dependent	 transporters	 (TBDTs)	 are	 a	 class	 of	 OMPs	 which	 allow	 active	translocation	of	essential	substances	such	as	iron	(chelates	to	specific	molecules	called	 siderophore),	 cobalt	 and	 nickel.	 It	 also	 allows	 the	 translocation	 of	substances	 such	 as	 vitamin	 B12	 and	 carbohydrates	 [49].	 To	 date,	 several	structures	 of	 TBDTs	 have	 been	 reported,	 including	 FhuA	 [50],	 FepA	 [51],	 PiuA,	PirA	 [52]	 and	 BtuB	 [53].	 Those	 structures	 revealed	 that	 the	 TBTDs	 are	 22-β	stranded	barrel	with	an	inner	“plug	domain”,	folded	back	inside	the	barrel	(Figure	1.6).			
	





As	no	source	of	energy	is	available	at	the	level	the	OM,	active	translocation	occurs	by	 transducing	 the	proton	motive	 force	 (pmf)	 generated	 in	 the	 IM	by	 a	protein	complex,	 namely	 TonB-ExbB-ExbD	 [49][54][55].	 Specifically,	 as	 a	 result	 of	 the	binding	of	the	ligand,	the	TBDTs	undertake	conformational	changes	that	lead	the	N-terminal	 of	 the	 plug	 domain,	 also	 known	 as	 TonB	 box,	 to	 reach	 and	 interact	with	 the	C-terminal	domain	of	 the	TonB	protein,	 at	 the	 level	 of	 the	periplasmic	space.	 Such	 interaction	 is	 necessary	 to	 transfer	 the	 energy	 for	 the	 ligand	translocation	 (Figure	1.7)	 [56],[57].	Although	 the	 crystal	 structure	of	 the	TonB-ExbB-ExbD	 complex	 has	 been	 recently	 determined	 [58],[59],	 the	 transport	mechanism	has	yet	to	be	understood.			
	 	










Recently	 the	 x-ray	 structure	 of	 the	 starch	 utilization	 system	 (SusCD)	 became	available,	 reveling	 a	 diverse	 example	 of	 TBDT	 [60].	 In	 fact,	 the	 SusCD	 complex	from	Bacteroides	thetaiotaomicron	solved	by	Glenwright	et	al.,	disclosed	a	novel	substrate-binding	mechanism	[60].	SusD	is	a	lipoprotein	that	acts	as	a	lid	on	the	top	of	SusC,	a	typical	22-β	stranded	TBTDs	(Figure	1.8).	In	absence	of	the	ligand,	SusD	is	in	an	open	and	motile	state	to	then	switch	to	a	closed	conformation	upon	ligand	binding.	The	 ligand	 is	 located	 in	between	 the	 interface	of	 SusC	and	SusD	[60].	As	for	the	case	of	the	canonical	TBDTs,	the	plug	domain	is	pushed	away	from	the	 barrel	 to	 interact	 with	 the	 TonB-ExbB-ExbD	 complex	 and	 complete	 the	translocation.			
	




	To	date,	only	few	outer-membrane	proteins	have	been	characterized	as	enzymes	[61],[62].	Those	OMPs	have	adapted	to	modify	the	outer-membrane	structure	as	a	response	 to	external	 stimuli	and	 threats	 [61].	For	 instance,	OmpT	porin	 from	E.	
coli,	 a	 well-characterized	 member	 of	 the	 omptine	 family,	 is	 involved	 in	 the	catalysis	of	antimicrobial	peptide	[63].	The	x-ray	structure	of	OmpT	showed	a	10	β-sheets	barrel	with	the	catalytic	residues	(D83,	D85,	D210,	H212)	placed	at	the	level	of	the	extracellular	loops	(Figure	1.9	A)	[64].	The	structural	organization	of	the	catalytic	pocket	 is	stabilized	due	 to	 the	 interaction	with	 the	LPS,	so	 that	 the	LPS	 is	 considered	 as	 a	 cofactor	 of	 OmpT	 [65].	 In	 silico	 modeling	 analysis	 have	suggested	 that	 a	molecules	 of	 water,	 located	 in	 between	 the	 residues	 D83	 and	H212,	 it	 is	 directly	 involved	 in	 the	 hydrolysis	 of	 the	 peptide	 bound	 of	 two	consecutives	basic	amino	acids	[66].		
	PagP	and	PagL	from	E.	coli	are	another	example	of	enzymatic	OMPs.	Both	porins	are	monomeric	and	8-β-stranded	and	are	involved	in	the	modification	of	the	LPS	[67],[68].	 Specifically,	 PagP	 and	 PagL	 undertake	 the	 palmitoylation	 and	 the	deacylation	 of	 the	 Lipid	 A,	 respectively[69],[70].	 Such	 modification	 have	 been	linked	 to	 an	 increase	 (palmytoylation)	 and	 a	 decrease	 (deacylation)	 of	 LipidA	endotoxicity	[71].				OMPLA,	 a	 monomeric	 12-β-stranded	 porin,	 is	 also	 involved	 in	 the	 LPS	modification.	 OMPLA	 is	 a	 calcium-dependent	 phospholipase	 able	 to	 hydrolyze	
Chapter	1:	Structure	and	function	of	outer-membrane	proteins	
	 17	
glycerophospholipids	 in	 the	 outer	 leaflet	 of	 the	 outer-membrane	 [72].	Interestingly	 the	monomeric	 form	 of	 this	 protein	 is	 inactive	 [73].	 Activation	 of	OMPLA	 occurs	 via	 dimerization	 and	 it	 is	 triggered	 by	 alteration	 of	 the	 LPS	asymmetry	[73],[74]	(Figure	1.9	B).		Further,	 LpxR	 and	 LpxQ	 have	 too	 been	 identified	 as	 OMP	 enzymes.	 They	 are	involved	 in	 the	 acyloxyacylation	 and	 oxidation	 of	 the	 Lipid	 A,	 respectively	[75],[76].	No	structural	information	is	yet	available	for	either	of	those	enzymes.			 	
	







1.1.6	Biosynthesis	of	OMPs		The	biosynthesis	of	OMPs	starts,	like	any	other	protein,	in	the	cytoplasm.	Several	proteins,	 often	 associated	 to	 form	multi-protein	 complexes,	 are	 involved	 in	 the	OMPs	 assembly	 [77],[78].	 Chaperones,	 both	 in	 the	 cytoplasm	 and	 in	 the	periplasm,	keep	 the	precursors	of	 the	OMPs	 (pre-OMPs)	unfolded	 [79],[80],	 the	SEC	complex	allows	the	pre-OMPs	to	pass	through	the	IM	and	finally	the	β-	barrel	assembly	machinery,	 also	 known	 as	 BAM,	 fold	 and	 insert	 the	 OMPs	 in	 the	 OM	(Figure	1.10)[81].			
		




















The	 majority	 of	 OMPs	 contains	 a	 signal	 peptide	 that	 allows	 the	 bacteria	 to	recognize	and	target	the	protein	to	the	correct	translocon.	The	signal	peptide	is	a	three-part	sequence,	 located	at	N-terminus	of	the	pre-OMPs	and	it	 is	usually	18-20	amino	acids	long	[82].	The	three	motifs	that	comprised	the	signal	peptide	are	identified	as	n-region	(at	the	N-terminus	of	the	sequence),	h-region	(composed	of	hydrophobic	 amino	 acids)	 and	 c-region	 (at	 C-terminus	 of	 the	 sequence,	 often	contains	an	A-A	consensus)[83].			A	two	proteins	complex,	SecAB,	is	responsible	to	deliver	the	pre-OMPs	to	the	SEC	translocon	[84].	SecA	is	an	ATP-powered	protein,	whose	role	is	to	carry	the	pre-OMPs	to	the	translocon,	while	the	chaperon	SecB	which	bounds	the	pre-OMPs	in	specific	 sequences,	 usually	 masked	 in	 the	 folded	 protein,	 keeps	 them	 unfolded	[85].		Although	 the	 majority	 of	 the	 proteins	 cross	 the	 IM	 maintaining	 an	 unfolded	conformation,	fully	folded	proteins	can	also	translocate	through	the	IM,	by	using	an	 alternative	 translocon,	 known	 as	 twin-arginine-translocase	 (TAT)	 [86].	 In	E.	
coli	 the	TAT	 system	consists	of	 three	 inner	membrane	proteins,	TatA,	TatB	and	TatC.		The	signal	peptide,	that	target	the	proteins	to	the	TAT	complex	includes	the	consensus	 sequence	 Ser/Thr-Arg-Arg-(X)-Phe-Leu-Lys	 (with	 X	 being	 any	 polar	amino	acid)[86].	When	the	proteins	reach	the	TAT	complex,	a	H+	proton	gradient	drives	the	proteins	through	the	translocon	to	the	periplasm	[87].			
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The	SecYEG	translocon	is	a	multi-protein	complex	composed	of	the	three	proteins	SecY,	 SecE	 and	 SecG	 [88].	 A	 homologue	 of	 the	 bacteria	 SEC	 translocon,	 the	translocon	 Sec61αβγ,	 has	 been	 identified	 in	 Eukaryotes	 [89].	 Although	 the	mechanism	 of	 translocation	 through	 the	 SEC	 complex	 has	 not	 been	 fully	understood,	 it	 is	clear	that	SecA	plays	a	major	role	[90].	During	translocation,	 in	fact,	SecA	partially	 insert	 itself	 through	the	translocon	pore	and	through	several	cycle	 of	 binding	 and	 hydrolysis	 of	 ATP	 gives	 the	 energy	 necessary	 for	 the	 pre-OMPs	to	translocate	[91][90].			In	 the	 SEC	 pathway,	 once	 the	 protein	 has	 crossed	 the	 IM,	 a	 signal	 peptidase	cleaves	the	signal	peptide	and	releases	 the	pre-OMPs	 in	 the	periplasm.	The	pre-OMPs	 are	 recognizes	 by	 different	 chaperons	 (SurA,	 Skp,	 FkpA	 and	 Spy)	 whose	role	 is	 to	 keep	 the	 pre-OMPs	 unfolded,	 avoiding	 their	 aggregation	 [92][93].	 In	case	 of	misfolded	proteins,	 a	 particular	 chaperone	with	 protease	 activity,	DegP,	binds	and	hence	degrades	 the	pre-OMPs	[94].	Once	the	chaperons	bind	the	pre-OMPs,	they	are	delivered	to	the	BAM	complex.		In	E.	coli	 the	BAM	machinery	 is	a	multi-protein	complex	composed	of	BamA,	an	outer-membrane	 protein,	 and	 four	 lipoproteins,	 BamBCDE,	 linked	 to	 the	 inner	leaflet	 by	 a	N-terminus	modification	 [95],	 [96].	 BamA	 is	 a	 16-β-stranded	 barrel	with	an	extended	periplasmic	domain	comprising	of	 five	repetitions	of	a	POTRA	(polypeptide-translocation-associated)	 domain	 (Figure	 1.11)	 [97],[98].	 The	POTRAs	present	a	β-α-α-β-β	architecture	and	although	structurally	identical	they	share	 low	 sequence	 identity.	 The	 POTRAs	 domain	 mediates	 BamA	 and	 BamB	
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interaction.	Deletion	of	 the	 last	 three	POTRAs	(P3-5)	 is	 lethal	 for	E.	coli,	but	not	for	 Neisseria	 gonorrhea	 [99],	 which	 implies	 that	 the	 importance	 of	 the	 single	POTRAs	on	the	bacterial	viability	is	species-specific.		
		








	Antibiotic	resistance	has	now	become	a	real	concern	for	public	health.	Particular	alarming	is	the	increasing	pace	at	which	resistance	pathogens	are	emerging,	while	the	Pharma	industries	are	struggling	to	find	new	classes	of	antibiotics	[106].		Gram-negative	bacteria	show	“intrinsic”	resistance	due	to	the	presence	of	the	OM	that	act	as	barrier	against	external	agents.	However,	hydrophobic	antibiotics,	such	as	aminoglycoside	and	chloramphenicol	can	penetrate	the	bacterial	cell	by	slowly	diffuse	through	the	OM	[107].	As	a	resistance	mechanism,	bacteria	can	modify	the	OM	 composition	 and	 hence	 alter	 its	 permeability.	 For	 instance,	 the	 pathogenic	bacteria,	 Salmonella	 enterica	 [108],	 has	 showed	 the	 ability	 to	 adjust	 the	composition	of	the	LPS,	following	the	host	colonization.	This	mechanism	is	due	to	the	presence	of	a	two	components	regulatory	system	PmrB-PmrA,	that	regulates	the	expression	of	genes	involved	in	the	modification	of	the	LPS	[109],[110].	Such	modifications	 include	 the	 incorporation	 of	 aminoarabinose	 and	phosphoethanolamine	 to	 the	Lipid	A,	which	decrease	 the	negative	charge	of	 the	LPS.	PmrBA	system	is	activated	by	the	presence	of	antibiotics	polypeptides,	such	as	 Polymixins	 B	 or	 colistins,	 and	 cationic	 antimicrobial	 peptides	(CAMPs)[110],[111].	 Those	 antibiotics	 bind	 to	 the	 anionic	 surface	 of	 the	 outer-membrane	 and	 hence	 gain	 access	 to	 the	 bacterial	 cells.	 In	 polimixins-resistant	strains	 a	 mutation	 in	 the	 PmrA	 gene	 lead	 to	 the	 expression	 of	 a	 constitutively	active	 PmrA	 and	 therefore	 to	 an	 high	 level	 of	 amminoarabinose	 and	phosphoethanolamine	 in	 the	 Lipid	 A,	 impairing	 the	 binding	 of	 polimixins	[111],[112].			
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[117],[118],[119].	Those	genes	are	activated	by	several	external	stimuli,	such	us	oxidative	 stress,	 pH	 changes	 and	 antibiotics	 [120].	 Once	 activated,	 they	 up-regulate	the	expressions	of	efflux	pumps,	such	as	TolC-AcrAB	and	small	RNAs	like	
micF	and	down-regulate	the	expression	of	porins	such	as	OmpF	[121],[122][123].	Point	 mutation,	 insertion	 element	 and	 deletion	 of	 those	 genes	 lead	 to	 a	 MDR	phenotype	 and	 to	 an	 increased	 minimum	 inhibitory	 concentration	 (MIC)	 for	different	classes	of	antibiotics[116],	[124],.		
	


































	First	 isolated	 in	 1913	 from	 an	 aborted	 lamb,	 Campylobacters	 were	 originally	wrongly	classified	in	the	genus	Vibrio	(Vibrio	fetus),	and	they	were	subsequently	identified	as	a	new	genus	(Campylobacter)	in	1973	[127].	To	date	15	species	and	6	subspecies	(both	commensal	and	pathogenic)	have	been	annotated	[128].		
	
Campylobacter	 spp.	 are	 gram-negative	 bacteria	 belonging	 to	 the	 class	 of	 ε-proteobacteria	 [129].	 Usually	 spiral	 or	 curve	 shaped,	 Campylobacter	 spp	 are	motile	by	means	of	a	single	or	bipolar	flagellum	[129].	They	belong	to	the	group	of	microaerophilic	and	thermophilic	bacteria,	meaning	that	a	modified	atmosphere	with	 a	 low	 concentration	 of	 oxygen	 and	 a	 high	 concentration	 of	 CO2,	as	well	 as	high	 temperatures	 (37-44°C),	are	necessary	 for	optimal	growth	 [6],	 [131],[132].	Growth	at	lower	temperatures	has	been	proven	to	be	slow	[132].			Particular	metabolic	characteristics	distinguish	Campylobacter	 from	other	gram-negative	 bacteria	 [133],[134].	 Campylobacter	 species	 are	 incapable	 of	 using	glucose	 or	 other	 carbohydrates	 as	 sources	 of	 energy	 due	 to	 the	 lack	 of	 the	glycolytic	 enzyme	 6-phosphofructokinase	 [135].	 Thus,	 organic	 acids,	 as	 well	 as	amino	acids,	such	as	serine,	proline	and	glutamic	acid	represent	their	main	source	of	 energy	 [136][137][138].	 In	 certain	 strains	 of	 C.	 jejuni,	 however,	 an	 L-fucose	pathway	 has	 been	 identified	 but	 not	 yet	 fully	 characterized	 [139].	 Accordingly,	gluconeogenesis	 appears	 to	 be	 fundamental	 for	 the	 production	 of	 glucose	 and	
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glucose-derivatives	 that	 are	 essential	 for	 lipopolysaccharide	 (LPS)	 and	 capsule	biosynthesis	and	hence	campylobacter	virulence	[134].		
2.1.2	Campylobacter	jejuni	infection			C.	jejuni	 and,	 to	a	 lesser	extent,	Campylobacter	coli	have	been	recognized	as	 the	main	 cause	 of	 bacterial	 gastroenteritis	 (campylobacteriosis)	 in	 both	 developed	and	 undeveloped	 countries	 [140],[141],[142].	 In	 recent	 years,	 other	
Campylobacter	 species,	 including	 C.	 concisus,	 C.	 ureolyticus,	 C.	 upsaliensis	 and	 C.	
lari,	have	been	associated	with	gastrointestinal	infections	and	have	been	classified	as	“emerging	pathogens”	[143].	Although	C.	jejuni	has	been	isolated	from	a	wide	range	of	organisms,	avians	(poultry	 in	particular)	are	considered	to	be	the	main	reservoir	 [144].	 Undercooked,	 contaminated	 poultry	 represents	 the	 primary	source	 for	 human	 infections.	 Contaminated	 water	 and	 unpasteurized	 milk	 can	also	 lead	 to	 infections,	 while	 human-to-human	 contamination	 is	 rare	 [145].	Motility,	cell	adhesion	and	cell	 invasion	are	critical	 factors	 that	mediate	C.	jejuni	virulence.	 In	 particular,	 the	 flagellum	 plays	 a	 central	 role	 in	 host	 colonization	[146].	 Classified	 as	 a	 Type	 3	 secretion	 system	 (T3SS),	 this	motile	 structure	 has	been	 shown	 to	 be	 responsible	 for	 the	 secretion	 of	 virulence	 factors	 inside	 the	cytosol	of	 its	host	 [147].	Additionally,	 several	proteins	 located	on	 the	surface	of	the	 bacteria	 contribute	 to	 the	 adhesion	 to	 the	 epithelium,	 enhancing	 C.	 jejuni	virulence	 [148].	Usually	 the	symptoms	of	 the	 infection	arise	within	3	days	after	ingestion	 of	 contaminated	 food,	 with	 symptoms	 lasting,	 on	 average,	 5-6	 days.		Commonly,	 people	 (in	 most	 cases	 children)	 infected	 with	 C.	 jejuni	 experience	
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abdominal	 cramps,	 bloody	 or	 watery	 diarrhea,	 weight	 loss	 and	 fever	 [144].	




Figure	 2.1:	 Mimicry	 mechanism	 in	 GBS	 associated	 to	 C.	 jejuni.	 Schematic	representation	of	human	ganglosides	GM1	and	C.	jejuni	LOS.	Figure	adapted	from	[29].							
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2.1.3	Campylobacter	jejuni	antibiotic	resistance		Antibiotic	 resistance	 in	C.	 jejuni	 has	 become	 a	 real	 concern	 in	 public	 health.	 As	
Campylobacter	 contamination	 among	 people	 is	 rare,	 the	 use	 of	 antibiotics	 in	animal	 farming	is	considered	to	be	the	main	cause	of	resistance	[157].	Although	the	European	Union	has	prohibited	the	addition	of	antibiotics	 in	animal	feed	for	non-therapeutic	purpose	(i.e.	growth	promotion	of	livestock),	in	other	part	of	the	world,	 the	 use	 of	 antibiotics	 as	 growth	 agents	 is	 still	 allowed	 [158].	 C.	 jejuni	strains	 isolated	 from	 contaminated	 poultry	 have	 shown	 resistance	 to	 different	classes	of	antibiotics	such	as	fluoroquinolone	(FQ),	macrolide	[159],	β-lactam	and	tetracycline	 [160][161][162]	 (Figure	 2.2).	 A	 multi-drug	 resistance	 (MDR)	phenotype	has	also	been	observed	[163][164].	The	macrolide	erythromycin	(Ery)	is	used	as	first	choice	treatment	when	campylobacteryosis	is	diagnosed.	However,	as	 campylobacteryosis	 is	 indistinguishable	 from	 other	 enteric	 infections,	Ciprofloxacin	 –	 an	 FQ	 with	 a	 broad	 spectrum	 activity	 against	 Gram-negative	bacteria	–	is	often	preferred	[160].		Antibiotic	 resistance	 in	C.	jejuni	 (as	 in	other	bacteria)	 is	 caused	mainly	by	 three	mechanisms:	 (i)	 Low	 OM	 permeability	 (ii)	 target	 alteration	 (ribosome,	 gene	mutation)	 and	 (iii)	 active	 efflux	 of	 antibiotics	 (CmeABC)[165],[166],[167].	Most	antibiotics	 enter	 the	 cell	 via	 non-specific	 porins.	 In	 general,	 porins	 govern	 the	translocation	of	 antibiotics	depending	on	 the	 charge	 and	 the	 size	of	 their	pores	[14].	In	E.	coli,	two	outer	membrane	proteins,	OmpC	and	OmpF	are	predominant.	In	 resistant	 clinical	 isolates,	 expression	 of	 OmpF	 (higher	 conductance)	 is	 down	regulated	 whilst	 expression	 of	 OmpC	 (lower	 conductance)	 is	 up	 regulated,	
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therefore	 translocation	 of	 antibiotics	 is	 decreased	 [125].	 Unlike	E.	 coli,	C.	 jejuni	has	 only	 one	 major	 outer	 membrane	 protein	 (MOMP),	 which	 has	 a	 molecular	weight	 limit	 of	 360	 Da,	 thus	 molecules	 with	 higher	 molecular	 weight	 cannot	permeate	 inside	 the	 cell	 [168].	 Additionally,	 being	 cationic	 selective,	 MOMP	represent	a	barrier	for	translocation	of	anionic	antibiotics	[168].		
	












	In	the	early	80’s,	Logan	and	Trust	identified	a	putative	porin	encoded	by	PorA,	of	an	 apparent	 molecular	 weight	 of	 45	 KDa	 located	 in	 the	 outer	 membrane	 of	 C.	
jejuni	[169].	This	protein	was	largely	expressed	in	the	OM,	and	therefore	named	as	major	outer	membrane	protein	(MOMP).	Predictions	of	 the	 tertiary	structure	suggested	 that	MOMP	resembled	 the	 typical	architecture	of	an	outer-membrane	porin,	 with	 an	 18	 β-strands	 barrel	 connected	 by	 loops	 and	 turns	 [170].	 The	presence	of	β-sheets	structures	was	suggested	by	circular	dichroism	(CD)	analysis	[171],[172].	Additionally,	examination	of	the	amino	acid	composition	showed	that	MOMP	was	comparable	to	the	two	major	porins	in	E.	coli,	OmpC	and	OmpF.	The	N-terminal	of	MOMP,	however,	displayed	significant	differences	[173].	MOMP,	in	vivo,	 adopts	 a	 trimeric	 arrangement,	 as	 shown	 in	 electron	 microscopic	 (EM)	experiments	[174].	In	solution,	detergents	and	temperature	have	been	suggested	to	 influence	 oligomerization.	 Extraction	 with	 increasing	 concentrations	 of	 SDS	and	heating	over	60	°C	leads	to	dissociation	of	the	trimer	into	folded	monomers.	Both	 folded	monomer	 and	 the	 trimer	 can	 be	 identified	 by	 SDS-PAGE	 at	 35	 kDa	and	 140	 kDa,	 respectively.	 Increasing	 the	 temperature	 up	 to	 96	 °C	 has	 been	shown	to	cause	a	shift	from	a	folded	to	an	unfolded	monomer,	which	is,	 instead,	identified	at	45	kDa	[171].	A	similar	behavior	was	described	for	the	trimeric	porin	PhoE	from	E.	coli[175].	Both	oligomeric	states	displayed	pore	activity	when	tested	in	 single	 channel	 experiments	 (with	 a	 conductance	 of	 400	 pS	 for	 the	monomer	and	1200	pS	for	the	trimer)	[176].	In	vitro,	MOMP	has	been	shown	to	participate	in	the	adhesion	of	C.	jejuni	to	human	epithelial	cells	[177],[178],[179].		
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Surface	 exposed	 antigens	 stimulate	 the	 immune	 system	 to	 produce	 antibodies	[180].	 In	 chicks,	 maternal	 antibodies	 have	 been	 proven	 to	 serve	 as	 protection	against	 C.	 jejuni	 infections	 [181].	 This	 inspired	 the	 idea	 to	 use	 C.	 jejuni	 surface	proteins	as	a	target	to	develop	vaccines.	However,	 in	chickens	and	mice	models,	immunization	 using	 CmeC	 subunit,	 the	 lipoprotein	 CjaA	 and	 PEB1	 antigen	 (all	surface-exposed	 proteins),	 have	 failed	 to	 protect	 from	 C.	 jejuni	 colonization	[182],[183],[184].	On	the	contrary,	MOMP-derived	vaccines	have	shown	promise.	MOMP	 contains	 antigenically	 variable	 regions	 at	 the	 level	 of	 the	 loops	 and	conserved	 regions	 present	 in	 the	 β-strands	 [170].	 Islam	 and	 co-workers	 have	already	 shown	 the	 protective	 effect	 of	 a	 recombinant	 MOMP-vaccine	 tested	 in	mice	models[185].	This	study	can	be	used	as	a	starting	point	to	generate	a	vaccine	for	 human	 use.	 Given	 that	 C.	 jejuni	 live	 attenuated	 vaccines	 could	 potentially	trigger	 auto-immune	 diseases,	 the	 use	 of	 a	 MOMP-derived	 vaccines	 would	represent	a	safer	alternative.	
2.1.5	Aims	
	Although	MOMP	 from	C.	 jejuni	 has	 been	 extensively	 studied	 over	 the	 last	 three	decades,	 only	 recently	 its	 crystal	 structure	 has	 became	 available	 (the	 structure	was	 solved	 by	Dr.	 Gregor	Wallat	 for	Naismith’s	 lab).	 Being	C.	 jejuni	 a	 fastidious	organism	to	cultivate,	Dr.	Wallat	successfully	over-expressed	and	purified	MOMP	from	E.	coli.			However,	 the	LPS	of	C.	 jejuni,	 differs	 from	 the	one	of	E.	coli,	with	a	 smooth	or	a	rough	O-antigen	phenotype.	To	address	concern	about	the	effect	of	the	LPS	on	the	
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Campylobacter	 jejuni	85H	 strain	 [45]	was	 grown	 according	 to	Bolla	 et	al.	 [171].	The	C.	jejuni	strain	was	spread	onto	a	blood	agar	plate	and	incubated	for	24	hours	at	 42	 °C.	 Bacteria	 were	 rinsed	 with	 1	 ml	 of	 2YT	 medium	 and	 agitated	 for	 15	minutes.	 Subsequently,	 250	 µl	 of	 the	 recovered	 bacteria	 were	 spread	 onto	 4	Columbia	 agar	 plates	 supplemented	 with	 the	 appropriate	 amount	 of	




	Cells	were	re-suspended	 in	300	ml	of	 lysing	buffer	 (Appendix	A.1)	and	 lysed	by	using	 two	 passes	 at	 30	 Kpsi	 through	 a	 high-pressure	 cell	 disruption	 for	 micro	volumes	 (Constant	 System	 Ltd).	 Unbroken	 cells	 were	 removed	 by	 spinning	 the	cell	 lysate	 at	 10,000xg	 for	 30	 minutes	 at	 4	 °C.	 Membranes	 were	 recovered	 by	ultracentrifugation	of	the	supernatant	at	100,000	x	g	for	1	hour	at	4	°C.	The	pellet	was	 then	 homogenized	 in	 10	 mM	 Tris-HCl	 pH	 7.4	 and	 0.1%	 (w/v)	 of	 sodium	lauryl	 sarcosinate	 (Sigma)	 and	 left	 rocking	 for	 30	 minutes	 at	 4	 °C.	 The	 outer	membrane	was	recovered	by	ultracentrifugation	at	100,000xg	for	1	hour	at	4	°C.	The	supernatant	containing	the	inner	membrane	proteins	fraction	was	discarded	and	the	pellet	was	homogenized	with	20	mM	sodium	phosphate	buffer	pH	7.4	and	1%	of	n-octylpolyoxyethylene	(Octyl-POE)	(Bachem	AG)	and	 left	 rocking	at	4	 °C	for	 30	 minutes.	 Solubilized	 outer	 membrane	 proteins	 were	 recovered	 by	ultracentrifugation	at	100,000xg	 for	1	hour	at	4	 °C.	At	 this	 stage,	 the	pellet	was	discarded	 and	 the	 supernatant	 was	 loaded	 onto	 a	 MonoQ	 HR	 ion	 exchange	column	(GE	Healthcare)	and	equilibrated	with	5	column	volumes	(CV)	of	buffer	A	(30	mM	Na2HPO4,	 10	mM	NaCl	 and	0.6%	Octyl-POE).	 The	bound	proteins	were	eluted	stepwise	with	5,	12,	20,	70	and	100%	of	buffer	A	supplemented	with	1	M	NaCl	(Appendix	A.1).	The	chromatography	was	performed	on	ÄKTA	Explorer	10	system	(GE	Healthcare).	Each	fraction	was	examined	with	SDS-PAGE	and	Western	blot	 with	 specific	 antibodies	 to	 test	 both	 purity	 and	 identity.	 Eluted	 fractions	containing	MOMP	were	 collected	 and	 concentrated	 to	 5	ml	 and	 injected	 onto	 a	Superdex	200	16/60	GL	(GE	Healthcare)	column	equilibrated	with	2	CV	of	10	mM	Tris-HCl	pH	8.0,	150	mM	NaCl	and	0.45%	(w/v)	of	tetraethylene	glycol	monooctyl	
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ether	 (C8E4)	 (Bachem).	 Fractions	 containing	 MOMP	 were	 combined	 and	concentrated	to	10	mg	ml-1.		
2.2.3	MOMP	85H	crystallization		












	X-ray	data	 from	a	crystal	of	MOMP	purified	 from	C.	jejuni	85H	were	collected	 in	house	 using	 a	 Rigaku	 Micromax™-007HF	 Cu	 anode	 with	 VariMax	 optics	 and	 a	Rigaku	 Saturn	 944+CCD	 detector	 and	 processed	with	 Xia2	 [186].	 The	 structure	was	 solved	 to	 a	 resolution	 of	 2.9	 Å	 by	 molecular	 replacement	 using	 the	recombinant	 MOMP	 structure	 (PDB	 code:	 5LDV)	 as	 a	 search	 model	 using	 the	program	 MR	 Phaser	 [187]	 .	 The	 model	 was	 manually	 built	 in	 Coot	 [188]	 and	refined	with	REFMAC5	 [189].	 Eventually,	 15	 TLS	 groups	were	 used	 in	 the	 final	refinement	cycle.	The	webserver	“CheckmyMetal”	[190]	was	used	to	validate	the	presence	of	calcium	molecules	at	the	constriction	zone	of	the	protein.				
	
	
pH	7	 pH	7.5	 pH	8	 pH	8.5	
30%	 A1	 A2	 A3	 A4	
31%	 B1	 B2	 B3	 B4	

























Campylobacter	 jejuni	 bacteria	were	 spread	 onto	 selective	 blood-agar	 plates	 and	grown	under	microaerophilic	 condition	 at	 42	 °C.	 	 At	 an	OD600	of	 2,	 the	 bacteria	were	 harvested	 by	 centrifugation.	 Due	 to	 a	 particular	 pigment	 produced	 by	Campylobacter,	the	cell	paste	displayed	a	pink	coloration.			
2.3.2	MOMP	extraction	and	purification		
	MOMP	from	the	native	Campylobacter	jejuni	was	purified	as	described	in	Bolla	et	
al.	 [173]	and	yielded	1	mg	of	protein	per	3	g	of	cell	paste.	A	canonical	 two	step	extraction	 protocol	 was	 used	 in	 order	 to	 separate	 inner	 and	 outer-membrane	proteins.	 MOMP	 purification	 was	 carried	 out	 using	 an	 anion-exchange	chromatography	followed	by	size	exclusion	chromatography.	The	anion-exchange	chromatogram	 showed	 two	 peaks	 eluting	 at	 22%	 and	 70%	 buffer	 B.	 Fractions	from	both	peaks	were	run	on	an	SDS	PAGE,	and	visualized	using	Coomassie	blue	stain.	The	SDS-PAGE	 showed	 that	 the	 expected	 two	bands,	 at	 45	kDa	and	at	50	kDa,	were	present	in	the	fractions	eluting	at	22%	buffer	B	(Figure	2.4	A	lane	1-4).	Mass-spectrometry	analysis	identified	the	band	at	45	kDa	as	MOMP,	and	the	band	at	 50kDa	 as	Omp50	 (see	 chapter	 3).	 The	majority	 of	MOMP,	 however	 eluted	 at	70%	buffer	B	 (Figure	2.4	A	 lane	5-9).	Only	 the	 fractions	containing	MOMP	(and	not	 Omp50)	 where	 used	 for	 further	 purification.	 During	 the	 size	 exclusion	chromatography	Octyl-POE	was	exchanged	to	C8E4,	a	more	suitable	detergent	for	
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2.3.3	MOMP	crystallization	and	structure	determination		The	MOMP	crystals	appeared	after	 three	days.	Crystals	were	 found	 in	condition	B3	 of	 the	 Mem	 Gold	 I	 crystallization	 screening	 (Molecular	 dimension).	 After	optimization	 using	 the	 hanging	 drop	 vapor	 technique,	 the	 largest	 crystals	were	found	in	0.05M	Calcium	chloride,	0.05	M	barium	chloride,	0.1	M	Tris-HCl	pH	8.5	and	30%	PEG	400	(Figure	2.5).	The	crystals	were	analyzed	with	an	in	house	X-ray	source	and	found	to	diffract	to	2.9	Å.	A	dataset	was	collected	and	processed	using	Xia2	 [186]	 in	 the	 space	 group	 P212121.	 Analysis	 of	 the	 Matthew’s	 coefficient	(Matthew’s	coefficient	of	2.64)	suggested	that	three	molecules	were	present	in	the	asymmetric	unit	(AS).	The	structure	was	solved	by	molecular	replacement	using	MR	 Phaser	 from	 the	 CCP4	 suite	 [187].	 As	 search	 model	 was	 used	 the	recombinantly	expressed	MOMP	(PDB	code:	5LDV).	The	quality	of	 the	structure	was	 assessed	 using	 Molprobity.	 Data	 collection	 and	 refinement	 statistics	 are	shown	in	table	2.2.			
	










Rfactor/Rfree	(%)	 23.9/27.1	N°	of	unique	reflections	 36693	N°	of	residues	 405	Water	 5		




























8	amino	acids	(Thr1	to	Lys8)	at	the	N-terminus	form	an	α-helix	that	points	away	from	 the	 barrel	 wall,	 toward	 the	 adjacent	 monomer.	 In	 this	 way,	 the	 three	 α-helices	(one	for	each	monomer)	form	a	triangle	that	faces	the	periplasmic	space	(Figure	2.7).			
	






















































2.3.7	Single	channel	conductance	measurements		MOMP	 conductivity	 was	 assessed	 by	 single	 channel	 measurements	 in	 10	 mM	Hepes	pH	6	and	1	M	KCl.	MOMP	was	randomly	inserted	into	the	bilayer	as	either	a	monomer	 or	 a	 trimer.	 Consequently,	 we	 detected	 two	 different	 levels	 of	conductance,	a	lower	one	of	0.7	±	0.2	nS,	and	a	higher	one	of	2.2	±	0.2	nS.	These	corresponded	 to	 the	monomeric	 and	 trimeric	 states,	 respectively.	The	 electrical	signature	showed	that	at	negative	voltages,	long	upward	spikes	occurred	for	both	
	 Interacting	molecule	 Bond	length	(Å)	
Calcium	binding	site	at	the	constriction	zone	Asp120	(Oxygen	 and	 side	chain)	 Ca2+	 2.33/2.29	Gln152	 Ca2+	 2.32	Asp155	 Ca2+	 2.32	Glu288	 Ca2+	 2.31	H2O	 Ca2+	 2.49	
Calcium	binding	site	in	between	monomers	Asp145		(Oxygen	 and	 side	chain)	 Ca2+	 2.29/2.3	Asn180	 Ca2+	 2.26	Gly72	 Ca2+	 2.27	Asn77	 Ca2+	 2.32	
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monomeric	 and	 trimeric	 MOMP.	 In	 contrast,	 at	 positive	 voltages,	 while	 the	monomer	 trace	was	 noisy	 (displaying	 long	 downward	 spikes),	 the	 trimer	 trace	was	silent	(Figure	2.10).			
	





buffer	at	a	final	concentration	of	10	mM).	Not	surprisingly,	the	electrical	trace	was	silent	at	positive	voltage	but	noisy	at	negative	voltage,	as	with	the	native	protein	(Figure	2.11	B).			In	 a	 control	 experiment,	we	 slowly	 replaced	 the	 buffer	 containing	 EGTA	with	 a	buffer	containing	10	mM	CaCl2.	As	expected	the	calcium	reverted	the	effect	of	the	chelating	agent,	resulting	in	an	entirely	silent	channel.		















	In	this	study,	we	present	the	first	X-ray	structure	of	the	natively	expressed	MOMP	from	 Campylobacter	 jejuni	 strain	 85	 H.	 Although	 previous	 analysis	 of	 two-dimensional	and	three-dimensional	crystals	of	MOMP	provided	a	clear	indication	of	the	trimeric	arrangement	of	the	protein,	similar	to	that	observed	for	OmpC	and	OmpF	 in	 E.	 coli,	 they	 failed	 to	 give	 complete	 structural	 data	 [194].	 The	 crystal	packing	of	the	structure	we	obtained	confirmed	this	trimeric	arrangement.	Each	monomer-monomer	 interface	 buries	 over	 1200	 Å2	 of	 surface	 area,	 while	 the	trimer	 buries	 almost	 10,000	 Å2	of	 surface	 area.	 Overall,	 the	 structural	 features	observed	 in	MOMP	 are	 common	 to	 all	 the	 porins	 characterized	 so	 far.	 A	 barrel	consisting	of	18-anti-parallel	β-strands	joined	together	by	long	extracellular	loops	and	short	periplasmic	turns.	The	L3	folds	back	inside	the	barrel	to	form	the	eyelet	of	the	pore,	a	region	characterized	of	negatively	and	positively	charged	residues	facing	 each	 other	 that	 create	 a	 strong	 electric	 field.	 L2	 stabilizes	 the	 trimer	 as	suggested	 by	 the	 several	 hydrogen	 bonds	 formed	 with	 the	 β-strands	 of	 the	adjacent	monomers.			A	 distinctive	 feature	 of	MOMP	 is,	 instead,	 the	 α-helix	 at	 the	 N-terminus,	 which	bends	outwards	reaching	the	neighboring	subunit	and	forms	an	α	-helix	triangle.	To	date,	only	two	outer-membrane	proteins	display	such	an	unusual	arrangement	at	 the	 N-terminal:	 OprB	 from	Pseudomonas	aeruginosa	 [195]	 and	 the	 palmitoyl	transferase	PagP	 from	E.	coli	[68]	 (Figure	2.13).	The	helix	 in	 these	 structures	 is	
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depicted	 EX,	 CR1	 and	 CR2,	 for	 both	 scenarios.”	 “For	 clarity,	 β-strands	 from	9	 to	 14	have	been	removed	from	the	cartoon	representation	of	MOMP	monomer.	Ciprofloxacin	is	represented	 in	 licorice.	 Interacting	 loops	are	highlighted	 in	orange	and	 labeled.	Specific	charged	residues	 interacting	with	ciprofloxacin	are	shown	 in	 licorice	colored	according	to	its	charge”.	Dr.	Silvia	Acosta-Gutierrez	provided	this	picture	and	the	caption.		
	
2.5.5	Comparison	between	recombinant	and	native	MOMP	
	A	 structure	 of	 MOMP	 recombinantly	 expressed	 in	 E.	 coli	 was	 obtained	 by	 Dr.	Gregor	Wallat	(Prof.	Naismith’s	laboratory).	We	compared	the	two	structures,	the	recombinant	and	the	natively	expressed	MOMP	and,	apart	from	small	differences	arising	 from	 the	 different	 crystal	 packing,	 the	 two	 structures	were	 structurally	identical	(r.m.s.d	0.45	Å	over	398	Cα	position)	(Figure	2.15).	Both	structures	have	a	 Ca2+	 ion	 bound	 at	 the	 constriction	 zone.	 Unlike	 the	 recombinant	 MOMP,	 the	
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natively	 expressed	 protein	 was	 crystallized	 in	 the	 presence	 of	 CaCl2.	 As	 a	consequence,	the	native	structure	has	an	extra	calcium	ion	located	at	the	interface	between	 monomers.	 The	 recombinant	 structure	 shows	 a	 different	 side	 chain	conformation	suggesting	that	 in	the	recombinant	protein	this	site	does	not	exist	and	it	is	an	artifact.		
	
Figure2.14:	 Superimposition	 of	 MOMP	 native	 (cyan)	 and	 MOMP	 recombinant	
(orange).	 View	 from	 the	 side	 (left)	 and	 from	 the	 top	 (right).	 The	 two	 structures	were	found	to	be	structurally	identical	with	a	r.m.s.d	of	0.45	Å	over	398	Cα	position.			
2.5.6	MOMP:	general	or	specific-substrate	porin?	
	As	 a	 general	 rule,	 18	 β-stranded	 porins	 are	 classified	 as	 substrate-specific.	 To	date,	 aside	 from	 MOMP,	 the	 only	 structures	 of	 trimeric	 18	 β-stranded	 porins	available	 are	 the	 structure	 of	 the	 maltoporin	 LamB	 from	 E.coli	 [200]	 and	 the	sucrose-porin	 SrcY	 from	 Salmonella	 tiphymurium	 [33].	 A	 distinctive	 feature	 of	both	LamB	and	SrcY	is	a	cluster	of	aromatic	amino	acids	(greasy	slide)	that	guides	the	 molecules	 of	 sugar	 through	 the	 porin	 channel	 [201],[202],[196].	 Although	
Chapter	2:	Major	outer-membrane	protein	from	Campylobacter	jejuni		
	 67	


























	Omp50	was	 first	 identified	as	 a	porin	of	C.	 jejuni	 85H	 in	a	 report	by	Bolla	et	al.	[203].	 Omp50	 was	 predicted	 to	 be	 an	 18-β-stranded	 monomeric	 porin.	Electrophysiology	experiments	demonstrated	the	ability	of	Omp50	to	form	a	pore	when	inserted	in	a	lipid	bilayer	[203].	Due	to	the	low	conductivity	(50-60	pS	in	1	M	 NaCl)	 exhibited,	 it	 was	 hypothesized	 that	 Omp50	 could	 represent	 a	 specific	porin	rather	than	a	general	one	[203].			The	 gene	 encoding	 for	Omp50	 (cj1170)	 is	 not	 ubiquitous	 in	Campylobacter	 and	therefore	 is	 used	 to	 differentiate	 Campylobacter	 species	 [204].	 Cj1170	 is	transcriptionally	 regulated	 in	 a	 temperature	 dependent	 manner	 [205]	 and	 up-regulated	in	the	presence	of	the	antibiotic	erythromycin	(Ery)	[206].	The	effect	of	Ery	on	the	up-regulation	of	Omp50	has	been	linked	to	its	proposed	kinase	activity	[206],[207].			Corcionivoschi	et	al.	first	suggested	Omp50	as	a	bacterial	tyrosine	(BY)	kinase	in	
C.	 jejuni	 11168	 strain	 [207].	 BY-kinases	 belong	 to	 a	 subgroup	 of	 kinase	 able	 to	auto-phosphorylate	on	several	 tyrosine	 [208].	Typically	embedded	 in	 the	 inner-membrane,	BY-kinases	consist	of	 two	transmembrane	α-helices	 link	together	by	an	external	loop	(also	known	as	hairpin	loop)	and	of	a	cytosolic	catalytic	domain.	The	 catalytic	 domain	 contains	 three	 different	 motifs:	 Walker	 A,	 Walker	 A’	 and	
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Walker	B	motif.	In	addition	to	the	three	motifs,	a	C-terminus	tyrosine	cluster	(YC)	is	also	found	in	the	catalytic	domain	[208].	Sequence	analysis	of	Omp50	led	to	the	identification	 of	 the	 Walker	 A	 and	 A’	 motifs	 (but	 no	 Walker	 B)	 motifs	 were	identified	in	Omp50	sequence	and	of	one	tyrosine	(Y338)	that	was	reported	to	be	essential	 for	 Omp50	 kinase	 activity.	 Mutation	 of	 this	 tyrosine	 suppressed	 the	tyrosine	kinase	pathway	in	C.	jejuni	1168,	suggesting	that	Omp50	is	the	only	BY-kinase	 in	 this	 organism.	 They	 also	 identified	 the	 enzyme	 UDP-	 GlcNAc/Glc	 4-epimerase	 (Gne)	 as	 one	 of	 Omp50’s	 substrates.	 It	 was	 suggested	 that	 Omp50	positively	regulates	Gne	activity	by	phosphorylating	a	tyrosine	(Y146)	in	its	active	site.	Considering	that	Gne	is	involved	in	the	formation	of	the	lipooligosaccharide	(LOS)	 and	 the	 capsule	 of	C.	 jejuni,	 Omp50	 kinase	 activity	 has	 been	 proposed	 to	have	 an	 impact	 on	 the	 permeability	 of	 the	 outer-membrane	 and	 therefore	 on	antibiotic	permeation.			
3.1.2	Aims		Omp50	 is	 a	 monomeric	 porin	 associated	 to	 antibiotics	 (especially	 macrolides)	resistance	in	C.	jejuni	[206].	To	date	no	structural	data	about	Omp50	are	available.		We,	therefore,	aimed	to	solve	the	structure	of	Omp50	using	X-ray	crystallography.	In	 order	 to	 do	 so,	 we	 first	 set	 up	 to	 purify	 Omp50	 from	 the	 native	 C.	 jejuni,	However,	due	 to	 the	 low	yield	obtained	we	decided	 to	 switch	 to	 a	 recombinant	system.	 We	 also	 set	 up	 to	 analyze	 the	 pore	 activity	 of	 the	 recombinantly	expressed	Omp50	in	lipid	bilayer	by	using	electrophysiology	measurements,	and	ultimately	compared	it	to	the	natively	expressed.	
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recognition	site,	however,	unlike	the	pTamA	vectors,	pTacHisTev	lacks	the	signal	peptide.	 Both	 Omp50	 gene	 and	 vector	 were	 digested	 using	 NcoI	 and	 HindIII	restriction	 enzymes	 (both	Promega)	 at	 37	 °C	 for	 3	 hours.	 Subsequently,	 2	 μl	 of	alkaline	 phosphatase	 (Promega)	was	 added	 to	 the	 vector	 and	 incubated	 for	 an	additional	30	minutes	at	37	°C.	The	Omp50	gene	and	the	pTacHisTev	vector	were	then	 ligated	 at	 room	 temperature	 (RT),	 overnight	 using	 a	 T4	 ligase	 (Promega).	The	 ligation	mixture	 was	 later	 used	 to	 transform	 DH5α	 cells.	 The	 transformed	cells	 were	 plated	 onto	 LB	 agar	 plates	 and	 supplemented	 with	 100	 μg/ml	 of	ampicillin.	 Colonies	 were	 picked	 and	 grown	 in	 10	 ml	 LB	 media	 supplemented	with	100	μg/ml	of	ampicillin	at	37	°C	and	shaken	at	200	rpm	overnight.	Cells	were	mini-prepped	using	the	commercial	kit	QIAprep®	Spin	Miniprep	Kit	(Qiagen)	and	the	plasmid	sent	for	sequencing	(GATC	Biotech).		
3.2.3	Single	base	site-directed	mutagenesis	
	Single	base	site-directed	mutagenesis	was	performed	to	substitute	the	tyrosine	in	position	348	with	a	phenylalanine	using	 the	method	described	by	Dr.	 Liu	 [209]	(Figure	3.1).	 Polymerase	 chain	 reaction	 (PCR)	was	 carried	 out	 using	 a	Pfu	 DNA	polymerase	 (Promega)	 and	a	 two	 stage	 amplification	 cycle	was	 chosen.	 Specific	primers	 were	 designed	 with	 overlapping	 and	 non-overlapping	 regions	 (Table	3.1).	The	PCR	product	was	then	incubated	with	2	μl	of	DpnI	(Promega)	(1U/μl)	at	37°	 C	 for	 4	 hours.	 This	 step	 ensured	 the	 total	 degradation	 of	 the	 methylated	(parental)	DNA.	To	check	the	amplification	efficiency,	a	small	aliquot	(5	μl)	of	the	digested	sample	was	analyzed	by	agarose	gel	electrophoresis.	Consecutively,	50	μl	
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DH5α	E.	coli	cells	were	transformed	with	100	ng	of	PCR	product,	plated	onto	LB	agar	plates	and	supplemented	with	100	μg/ml	of	ampicillin.	Colonies	were	picked	and	grown	at	37	°C,	200	rpm	overnight	in	10	ml	LB	media	supplemented	with	100	μg/ml	of	ampicillin.	Then	cells	were	subsequently	spun	down	at	4,000x	g	for	10	minutes	at	4	°C	and	mini-prepped	using	a	QIAprep®	Spin	Miniprep	Kit	(Qiagen).	To	 confirm	 the	 presence	 of	 the	mutation,	 the	 plasmid	was	 sent	 for	 sequencing	(GATC	Biotech).				
	




















37	°C	 for	3	hours	after	 induction.	Due	 to	 the	 low	yield	obtained	 for	 the	purified	Omp50,	auto-induction	media	for	large-scale	was	attempted.			The	starter	culture	was	prepared	by	inoculating	100	ml	of	LB,	containing	100	μg	ml-1	of	ampicillin	and	1%	(w/v)	of	glucose	(Sigma),	with	one	colony	of	plasmid-transformed	C43(DE3).	After	overnight	growth	at	37	°C,	10	ml	of	the	start	culture	was	 used	 to	 inoculate	 12x400	 ml	 of	 ZYP-5052	 media	 supplemented	 with	ampicillin.	 Adequate	 aeration	 is	 essential	 to	 reach	 an	 optimum	 level	 of	 protein	expression,	therefore	no	more	than	400	ml	of	media	was	used	in	2	L	baffled	flasks.	The	 culture	was	 incubated	 at	 20	 °C	 and	 shaken	 at	 250	 rpm	 for	 48	 hours.	 Cells	were	 harvested	 by	 centrifugation	 at	 6,000x	 g	 at	 4	 °C	 for	 10	minutes	 (rotor	 JLA	8.100,	Beckman).	
3.2.6	Purification	of	Omp50	Wt	and	Omp50	Y348F	
	To	purify	Omp50	Wt	and	Omp50	Y348F,	100	g	of	cell	paste	was	resuspended	in	400	 ml	 of	 lysing	 buffer	 and	 lysed	 with	 two	 passes	 at	 30	 kpsi	 through	 a	 high-pressure	cell	disruption	system	(Constant	System	Ltd).	Debris	were	removed	by	spinning	down	the	lysed	cells	at	15,000x	g	at	4	°C	for	15	minutes	(rotor	JA	25.50,	Beckman).	Total	membranes	were	recovered	by	ultracentrifugation	at	100,000	x	g,	4	°C	for	1	hour	(rotor	Ti5.2,	Beckman).	The	pellet	was	homogenized	in	50	mM	Na3PO4	pH	8,	250	mM	NaCl,	10	mM	β-mercaptoethanol	(BME)	and	7	%	Octyl-POE.	Solubilized	 membrane	 were	 left	 stirring	 overnight	 at	 4	 °C.	 The	 following	 day,	insoluble	material	was	removed	by	ultracentrifugation	at	100,000	x	g	and	4°C	for	1	hour.	The	supernatant	(approximately	200	ml)	was	then	incubated	with	5	ml	of	
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nickel	 nitriloacetic	 acid	 (Ni-NTA)	 resin	 (Qiagen)	 at	 4°C,	 stirring	 for	 1	 hour.	 The	resin	was	 previously	washed	 twice	with	water	 to	 remove	 the	 ethanol	 used	 for	storage,	 and	 ultimately	 equilibrated	 with	 the	 buffer	 used	 for	 the	 protein	extraction.	 After	 2	 hours,	 the	 sample	 was	 loaded	 onto	 a	 100	 ml	 gravity	 flow	column	(BIO-RAD)	and	the	flow	through	collected.	The	resin	was	washed	with	10	CV	 of	 washing	 buffer	 supplemented	 with	 5	 mM	 BME	 and	 eluted	 with	 2	 CV	 of	elution	 buffer	 also	 supplemented	 with	 5	 mM	 BME	 (Appendix	 A.2).	 The	 eluted	protein	was	then	dialyzed	against	500	ml	of	dialysis	buffer	(Appendix	A.2)	at	4°C	for	30	minutes	to	reduce	the	concentration	of	imidazole.	A	snakeskin	membrane	(Thermo	scientific)	with	a	10	kDa	cut	off	was	used	during	dialysis.	Subsequently,	His-tagged	TEV	 protease	was	 added	 to	 the	 protein	 to	 a	 final	 ratio	 of	 1:10	TEV:	protein.	The	protein	was	left	in	dialysis	overnight	at	4°C.	The	next	day,	the	sample	was	 filtered	 through	 a	 0.45	 μm	 filter	 and	 applied	 to	 a	 5	 ml	 His-trap	 column	(Qiagen)	using	a	peristaltic	pump.	At	this	point	the	cleaved	protein	flowed	though	the	column	while	the	His-tagged	TEV	remained	bound.		The	cleaved	protein	was	then	concentrated	to	5	ml,	spun	down	at	14,000	rpm	for	15	minutes	(centrifuge	5417R,	 Eppendorf),	 and	 loaded	 onto	 a	 16/60	 200	 pg	 superdex	 column	 (GE	healthcare)	 that	was	equilibrated	with	2	CV	of	10	mM	Tris-HCl	pH	8.0,	150	mM	NaCl	 and	 either	 0.45%	 C8E4,	 1%	 N,N-Dimethyldodecylamine	 N-oxide	 (LDAO)	(Sigma),	1%	n-Octyl-β-D-Glucopyranoside	(OG)	(Anatrace)	or	1%	n-Dodecyl	β-D-maltoside	(DDM)	(Anatrace).		The	protein	was	then	concentrated	to	10	mg	ml-1.				
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	Initial	 trials	 were	 done	 using	 several	 commercial	 screens.	 The	 screens	 were	dispensed	 into	 a	96-well	 sitting	drop	plate	 (Intelli-Plate®,	ARI)	using	 a	Gryphon	robot,	at	a	protein:reservoir	ratio	of	1:1	and	1:2.	First	hits	appeared	within	three-four	weeks.	When	necessary,	crystallisations	conditions	were	manually	optimized	by	the	hanging-drop	vapor	diffusion	technique.	In	order	to	improve	the	quality	of	the	crystals,	commercial	additive	screens	were	explored,	and	were	also	dispensed	using	the	Gryphon	robot.			
In	situ	proteolysis	of	Omp50	was	also	attempted	using	different	proteases.	Stock	solution	 at	 1	 mg/ml	 of	 Subtilis	 A,	 Trypsin,	 Chemotrypsin	 and	 Papain	 were	prepared	in	specific	buffers	(listed	in	Appendix	A.2)	flash	frozen	in	liquid	nitrogen	and	stored	at	–	20°C.	Omp50,	at	a	concentration	of	10	mg/ml,	was	incubated	at	RT	for	 an	 hour	 with	 different	 proteases	 at	 a	 final	 ratio	 of	 either	 1:10	 or	 1:100	protein:protease.	 The	 reaction	 was	 stopped	 by	 adding	 LDS	 loading	 buffer	(Promega).	Omp50	proteolytic	products	were	checked	by	SDS-PAGE.		
	
3.2.9	Lipid	cubic	phase	(LCP)	
	To	 set	up	LCP	plate	we	used	 the	method	described	by	Caffrey	 and	Porter[210].	Briefly,	 Omp50,	 at	 a	 concentration	 of	 15	 mg/ml,	 was	 mixed	 with	 monoolein	(Molecular	Dimension)	at	a	final	ratio	of	2:3	protein:monoolein.	The	glass	syringe	and	the	tip	used	to	mix	the	protein	and	the	monoolein	was	quickly	warmed	up	at	42°C	 on	 the	 top	 of	 a	 heating	 block.	 This	 prevented	 the	 monoolein	 solidifying	
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during	the	mixing.	Care	was	taken	to	avoid	bubbles	during	this	process.	Once	the	mixing	was	completed,	the	syringe	was	attached	to	the	Gryphon	robot.	Previously,	several	LCP	glass	plates	were	prepared	as	 follows.	The	plates	were	coated	with	Rainex	 and	 left	 to	 dry	 for	 a	 few	minutes.	 Consecutively,	 the	 plates	were	 rinsed	with	 milliQ	 water	 and	 dried	 with	 a	 tissue.	 Once	 dried,	 a	 96-well	 spacer	 was	stacked	on	 the	 top	of	 the	each	of	 the	glass	plates.	The	distance	between	the	 left	edge	of	the	plate	and	the	spacer	was	roughly	0.5	cm,	while	the	distance	between	the	 right	 edge	 and	 spacer	 was	 roughly	 1.5	 cm.	 The	 plates	 were	 placed	 on	 the	metal	base	of	the	Gryphon	robot.	Several	commercial	screens	were	dispensed.	For	each	 well,	 the	 Gryphon	 dispensed	 800	 nl	 of	 reservoir	 and	 50	 nl	 of	 the	protein/monoolein	 mixture.	 Once	 the	 process	 was	 completed,	 the	 plates	 were	removed	from	the	Gryphon	and	covered	with	a	glass	coverslip	and	imaged	using	a	Ministrel	device	(Rigaku).		
3.2.10	Single	channel	conductance	analysis	of	Omp50	




	Omp50,	 Wzc	 (positive	 control)	 and	 Omp36	 (negative	 control),	 all	 at	 a	 final	concentration	of	1	mg/ml	were	run	on	a	SDS-PAGE	gel.	Omp50	and	Y348F	Omp50	were	incubated	with	10	mM	MgCl2	and	1	mM	ATP	for	1	hour	at	RT.	A	pre-stained	ladder	 (Novex®	 Sharp	 Pre-stained,	 Life	 Technology)	was	 used	 for	 the	 standard.	The	 gel	 was	 run	 for	 35	 minutes	 at	 200	 V	 and	 subsequently	 transferred	 for	blotting.	 Six	 pieces	 of	 blotting	 paper	 were	 cut	 and	 soaked	 in	 different	 buffers	(Appendix	A.2).	One	piece	of	paper	was	soaked	in	anode	buffer	1,	two	pieces	were	soaked	in	anode	buffer	2	and	the	last	three	pieces	were	soaked	in	cathode	buffer.	A	piece	of	polyvinylidene	difluoride	(PVDF)	membrane	(Sigma)	(same	size	of	the	gel)	 was	 pre-soaked	 in	 50	 ml	 of	 methanol	 (Sigma).	 The	 blotting	 stack	 was	assembled	 by	 the	 placement	 of	 the	 two	 pieces	 of	 blotting	 paper	 soaked	 in	 the	anode	buffer	1	at	the	bottom	of	the	stack,	followed	by	the	anode	buffer	2	soaked	paper,	 the	 PDV	 membrane,	 the	 gel	 and	 finally	 the	 three	 papers	 soaked	 in	 the	cathode	buffer.	The	 transfer	was	performed	using	a	 semi-dry	 transfer	 cell	 (Bio-RAD),	applying	25	V	for	1	hour.	A	blocking	solution	was	made	by	dissolving	2.5	g	of	milk	 powder	 in	 50	ml	 PBS.	 The	membrane	was	 placed	 inside	 a	 50	ml	 falcon	tube	filled	with	the	blocking	solution	and	left	rolling	for	1	hour	at	4°C.	Then	the	blocking	solution	was	poured	off	and	replaced	with	10	ml	PBS	supplemented	with	a	 1:1000	 dilution	 of	 monoclonal	 anti-phosphotyrosine-peroxidase	 antibody	(Sigma-Aldrich)	and	left	rolling	for	1	hour	at	4°C.	The	antibody	stock	solution	was	prepared	 according	 to	 manufacturer’s	 instructions.	 The	 membrane	 was	 then	washed	 3	 times	with	 40	ml	 of	 PBS	 to	 remove	 excess	 antibody.	 To	 develop	 the	western	blot,	equal	amounts	(1	ml)	of	detection	reagents	(SuperSignal®	West	Pico	
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Chemiluminescent	 substrate,	 Thermo	 Scientific)	were	 applied	 to	 the	membrane	prior	to	imaging	with	a	ChemiDoc	imager	(Bio-RAD).	
	
3.2.12	Radioactive-thin	layer	chromatography	(TLC)		






























10mM Tris pH8	 ✓	 ✓	 ✓	 ✓	 ✓	
10 mM MgCl2	 ✓	 ✓	 ✓	 ✓	 ✓	
150 mM NaCl	 ✓	 ✓	 ✓	 ✓	 ✓	
0.45% C8E4	 	 	 	 ✓	 ✓	
2 mM D-glucose 	 ✓	 	 	 	
1U/µl Apyrase ✓	 	 	 	 	
1U/µl Hexokinase 	 ✓	 	 	 	
4,6,8,or 10 µM Omp50 	 	 	 ✓	 	
8 or 10 µM 
Omp50Y348F 
	 	 	 	 ✓	





3.3.1	Omp50	purification	from	the	native	C.	jejuni	85H	strain		The	purification	protocol	 from	Bolla	et	al	 allowed	 the	 extraction	of	both	MOMP	and	Omp50	porins	from	the	outer-membrane	of	C.	jejuni	(Chapter	2,	Figure	2.3).	However,	the	level	of	the	expression	and	so	the	final	yield	of	purified	Omp50	was	very	 low	 and	 not	 useful	 for	 crystallographic	 studies.	 Therefore,	 no	 further	experiments	were	 carried	out	using	Omp50	natively	 expressed	 in	C.	 jejuni	85	H	strain.		
3.3.2	Omp50	recombinant	expression	and	purification		Omp50	was	overexpressed	with	either	an	N-terminus	or	a	C-terminus	His6-tag	in	several	cell	lines.	The	level	of	expression	of	Omp50	with	the	C-terminus	His6-tag	was	 low	 and	 therefore	 no	 further	 experiments	 were	 carried	 out	 with	 this	construct.	N-terminus	tagged	Omp50	showed	higher	levels	of	expression	and	was	consequently	 used	 for	 small	 and	 large-scale	 purification.	 Omp50	 was	overexpressed	in	C43(DE3)	cell	line	using	TBP	media	and	inducted	at	high	OD600	at	37	°C	for	3	hours.	Omp50	was	extracted	using	Octyl-POE,	isolated	using	nickel	resin,	TEV	cleaved	and	further	purified	using	size	exclusion	chromatography.	The	SEC	 profile	 showed	 a	 single	 peak,	whose	 fractions	were	 analyzed	 by	 SDS-PAGE	and	identified	as	Omp50	by	MS;	(Figure	3.2	A-B)	the	purified	peak	yielded	0.2	mg	L-1	of	protein	culture.	In	order	to	improve	the	final	yield,	Omp50	was	over-expressed	in	C43(DE3)	using	
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3.3.3	Omp50	crystallization		Crystallization	of	Omp50	was	carried	out	against	several	commercial	screenings.	Most	of	 the	drops	were	clear	or	were	displaying	 large	amounts	of	precipitation.	However,	small	cubic	crystals	appeared	after	approximately	4	weeks	(Figure	3.3).	The	crystals	were	confirmed	to	be	protein	crystals	due	 to	absorbance	under	UV	light.	When	 tested,	however,	 they	showed	no	diffraction.	Attempts	 to	reproduce	and	 optimized	 the	 crystals	 were	 unsuccessful.	 Additive	 screening	 also	 did	 not	improve	the	reproducibility	of	the	crystals.			
	
Figure	 3.3:	 Crystallisation	 of	 Omp50.	 Crystals	 grown	 using	 the	 sitting	 drop	 vapor	technique.	(A)	Under	visible	light	(B)	Under	UV	light		




trials.	 Unfortunately,	 the	 use	 of	 limited	 proteolysis	 did	 not	 improve	 the	crystallization	of	Omp50.			
	
Figure	 3.4:	 SDS	 gel	 of	 Omp50	 proteolitic	 products.	 SDS	 gel	 of	 the	Omp50	products	obtained	by	limited	proteolysis	using	subtilisA,	trypsin,	chemotrypsin	and	papain.			
3.3.4	Lipid	cubic	phase	(LCP)	













































































	Omp50	conductivity	was	assessed	by	single	channel	measurements	in	1	M	KCl,	10	mM	 MES	 pH	 6.	 Omp50	 inserted	 was	 into	 the	 bilayer	 as	 a	 monomer	 with	 a	conductance	of	53±0.2	pS.	The	insertion	of	the	protein	was	difficult	to	achieve	and	the	 channel	 became	 unstable	when	 a	 voltage	 higher	 than	 100	mV	was	 applied.	The	 channel	 showed	 a	 high	 flickering	 rate,	 which	 is	 clear	 from	 the	 ion-current	trace	(Figure.	3.5).			
	 	




3.3.6	Western	blot	with	antibodies	anti	phosphorylated	tyrosine		Omp50	 auto-phosphorylation	 activity	 was	 assayed	 by	 western	 blot	 using	 an	antibody	against	phosphorylated	 tyrosine.	Wzc-	an	E.	coli	BY-kinase	 involved	 in	the	capsule	biosynthesis-	was	used	as	a	positive	control,	while	Omp36	–	a	general	porin	 from	Enterobacter	aerogenes	 –	was	 used	 as	 negative	 control.	 Omp50	was	analyzed	before	and	after	incubation	with	MgCl2	and	ATP.	In	both	cases	we	could	not	detect	any	phosphorylated	tyrosine	(Fig.	3.6).			
	


























































In	 collaboration	 with	 Prof.	 Panos	 Sultanos	 and	 Dr.	 Mahdavi	 (University	 of	Nottingham),	 we	 were	 able	 to	 purify	 Omp50	 from	 the	 native	 C.	 jejuni	 11168	strain,	the	same	strain	used	for	the	experiments	performed	by	Corcionivoschi	et	
al.	We	repeated	 the	WB	with	antibodies	anti	phosphorylated	 tyrosine,	however,	also	in	this	case,	we	did	not	detect	any	phosphorylation	(Figure	3.7).			
	















































































C.	 jejuni.	 Unfortunately,	 due	 to	 the	 low	 level	 of	 the	 expression,	 the	 amount	 of	protein	 purified	 was	 not	 sufficient	 to	 start	 crystallization	 trials.	 Since	
Campylobacter	are	 fastidious	 to	grow	under	 laboratory	conditions,	 the	option	of	growing	 a	 larger	 quantity	 of	 bacteria	was	 rejected	 and	 recombinant	 expression	was	attempted	instead.		Omp50	was	 recombinantly	 over-expressed	 in	 C43(DE3)	E.	coli	 cells	 using	 auto-induction	 media.	 The	 purified	 protein	 was	 used	 in	 crystallization	 trials	 and	crystals	were	obtained	within	a	month.	However	no	diffraction	was	detected.	To	date,	 our	 attempts	 to	 reproduce	 and	 improve	 the	 crystals	 using	 various	techniques	have	been	unsuccessful.			
3.4.2	Homology	predictions	

























coli	 exhibits	 a	 conductance	 of	 53±0.2	 pS.	 Previously,	 Bolla	 et	 al.	 measured	 the	conductivity	of	the	native	Omp50[203],	and	we	found	those	measurements	agree	with	ours.	Omp50	conductance	is	similar	to	the	conductance	of	the	specific	porins	from	P.	aeruginosa	Occk4	and	Occk6	(43±11pS	and	71±34pS,	respectively)[214].	Conversely,	 unlike	 the	Occk	porins,	which	 showed	anion	 selectivity,	Omp50	has	been	shown	to	be	cation-selective	[203].	
	
3.4.4	Omp50	putative	tyrosine	kinase	activity		It	was	the	publication	of	Corcionivoschi	et	al.[207],	that	 led	us	to	investigate	the	allegedly	kinase	activity	of	Omp50.	BY-kinases	are	typically	constituted	of	two	α-helices	 spanning	 the	 inner	 membrane	 with	 the	 catalytic	 domain	 facing	 the	cytoplasm	[215],[208],[216].	Omp50,	however,	has	been	predicted	to	be	a	barrel	of	18	β-sheets	located	in	the	outer-membrane,	hence	significantly	different	from	a	typical	BY-kinase	structure.	Moreover,	while	ATP	concentration	in	the	cytoplasm	ranges	from	1-3	mM	[217],	it	has	been	shown	to	be	absent	or	considerably	low	in	the	periplasmic	and	in	the	extra-cellular	space	[218].	It	is	a	question	as	to	where	the	ATP	for	the	phosphorylation	of	Omp50	and	its	substrates	would	come	from.					
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Enterobacter	 aerogens	 are	 facultative	 anaerobic	 and	 opportunistic	 bacteria	belonging	 to	 the	 family	 of	 Enterobacteriacea,	 frequently	 isolated	 from	 the	respiratory	 and	urinary	 system	of	hospitalized	patients	 [219],[220].	E.	aerogens	infections	have	been	associated	with	high	levels	of	morbidity	and	mortality	[221].	For	 example,	 in	 Nepal	 in	 1999,	 E.	 aerogens	 infections	 led	 to	 an	 outbreak	 of	septicemia	in	a	neonatal	intensive	care,	causing	the	death	of	12	new	borns	[222].		Moreover,	an	increased	number	of	E.	aerogenes	strains,	isolated	from	nosocomial	patients,	 have	 exhibited	 a	 multi-drugs	 resistance	 (MDR)	 phenotype.	 MDR	 E.	
aerogens	strains	have	been	identified	all	over	Europe	[220].	The	expression	of	an	extended-spectrum	 β-lactamase	 [223],	 TEM-24	 [224],	 chromosomal	cephalosporinase,	and	recently	acquired	carbapenemases	confer	resistance	to	β-lactams	 [225],	 carbapenems	 along	 with	 resistance	 to	 the	 first	 generation	cephalosporin	 [226],[227].	 In	France,	 a	pan-drug	 resistant	 clone	of	E.	aerogenes	(EA1509E)	 has	 been	 isolated	 from	 a	 nosocomial	 patient,	 that	 was	 found	 to	 be	resistant	 to	 all	 the	 clinical	 relevant	 antibiotics	 with	 the	 only	 exception	 of	gentamycin	[228].	Similarly	in	Belgium,	several	patients	(aged	from	7	to	85	years)	were	 infected	with	 a	 clone	of	MDR	E.	aerogenes	 susceptible	 only	 to	 gentamycin	and	imipenem	[229].			
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In	 general,	 MDR	 is	 a	 complex	 mechanism	 regulated	 at	 different	 levels.	 Several	genes,	including	MarA,	RamA,	SoxS	are	involved	in	regulation	of	MDR,	specifically,	by	 up-regulating	 the	 expression	 of	 efflux	 pumps	 and	 down-regulating	 the	expression	 of	 porins	 [230],[231].	 Mutations	 and	 overexpression	 of	 these	 genes	have	 been	 linked	 to	 a	 high	 level	 of	 antibiotic	 resistance	 [230].	 In	 particular,	 an	overexpression	 of	 MarA	 has	 led	 to	 a	 2-	 to	 16-	 fold	 increase	 in	 resistance	 to	carbapenems	and	fluoroquinolones	in	E.	aerogenes	ATCC	13048	strain	[230].		
4.1.2	Enterobacter	aerogenes	porins	
		Two	major	 general	porins	 are	 found	 in	E.	aerogenes,	Omp35	 (OmpF-like	porin)	and,	Omp36	(OmpC-like	porin)[232].	Omp35	is	a	trimeric	porin	usually	expressed	under	low	osmolarity	conditions.	Pore	activity	of	Omp35	has	been	confirmed	by	single	 channel	 measurements	 of	 conductivity	 and	 cation	 selectivity	 have	 been	reported;	 these	values	are	similar	 to	what	has	been	observed	 for	OmpF	 from	E.	
coli	(4.22	nS	measured	at	pH	7)	[232].	Omp36	is	a	trimeric	porin	(homologous	of	OmpC	 from	 E.	 coli	 and	 OmpK36	 from	 K.	 pneumonia)	 expressed	 under	 high	osmolarity	conditions	[233].		In	MDR	E.	aerogenes	 isolates,	 porin	 expression	was	observed	 to	be	 significantly	altered[234][235].	 In	 ertapenem-resistant	 isolates	 the	 expression	 of	 Omp35	 is	down	 regulated	and	eventually	 completely	 suppressed	 [236].	 In	 ertapenem	and	imipenem-resistant	 isolates,	 along	 with	 Omp35,	 Omp36	 expression	 is	 also	suppressed	 [235].	 In	 clinical	 isolates,	mutations	 of	 the	 L3	 in	 Omp36	 have	 been	
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associated	 with	 antibiotic	 resistance	 [233].	 Most	 strikingly	 substitution	 of	 a	glycine	to	an	aspartic	acid	in	position	112	has	been	shown	to	decrease	the	uptake	of	β-lactams	and	cephalosporin[11].		
4.1.3	Aims	













	Cell	 pellets	 were	 re-suspended	 in	 lysis	 buffer	 (5-10	ml	 of	 buffer	 per	 gr	 of	 cell	paste)	(Appendix	A.3)	and	lysed	by	two	passes	through	a	chilled	cell	disruptor	at	30	 kpsi.	 Cellular	 debris	 were	 removed	 by	 centrifugation	 at	 10,000	 g	 (JA	 25.50	rotor,	 Beckman	 Coulter).	 The	 total	 membrane	 fraction	 was	 collected	 by	ultracentrifugation	 at	 100,000	 g	 (50.2	 Ti	 rotor,	 Beckman	 Coulter)	 at	 4	 °C	 for	 1	hour.	The	membranes	were	solubilized	in	50	mM	Na3PO4	pH	8,	250	mM	NaCl	and	7%	 Octyl-POE	 and	 left	 stirring	 at	 4°C	 overnight.	 Soluble	 material	 was	 then	recovered	by	ultracentrifugation	at	100,000	g,	at	4°C	for	1	hour.	The	supernatant	containing	 the	 solubilized	 protein	 was	 incubated	 with	 5ml	 of	 Ni-NTA	 resin	(Qiagen,	UK)	and	10	mM	imidazole	pH	8	at	4°C	 for	2	hours.	The	resin	was	 then	washed	with	 10	 CV	 of	washing	 buffer;	 50	mM	Na3PO4	pH	 8,	 250	mM	NaCl,	 1%	Octyl-POE	 and	 30	 mM	 imidazole	 pH	 8.	 The	 protein	 was	 eluted	 with	 the	 same	buffer	containing	250	mM	imidazole.	1	mg	of	His6-tagged	TEV	protease	was	added	to	the	eluted	protein	and	dialyzed	in	SnakeSkin	tubing	(Thermo	Scientific)	against	a	buffer	containing	10	mM	imidazole	at	4°C	overnight.	The	dialyzed	sample	was	passed	through	a	0.45	μm	syringe	filter	and	applied	to	a	5	ml	His-trap	column	(GE	Healthcare).	 The	 cleaved	 protein	 was	 collected	 from	 the	 flow-through	 fraction	and	 further	 purified	 by	 gel	 filtration	 using	 a	 16/	 60	 Superdex	 200	 pg	 (GE	Healthcare)	equilibrated	with	2	CV	of	a	buffer	containing	10	mM	Tris-HCl	pH	8,	150	mM	NaCl	and	0.45%	(w/v)	C8E4.	The	protein	was	concentrated	to	10	mg	ml-1	
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for	 crystallization.	 Purity	 and	 integrity	were	monitored	on	 SDS-PAGE	 (NuPAGE,	Invitrogen)	and	mass	spectrometry.			
4.2.3	Omp35	and	Omp36	crystallization				Different	 commercial	 screens	 were	 used	 for	 initial	 trials	 (Appendix	 B).	 The	screens	were	dispensed	into	a	96-well	sitting	drop	plate	(Intelli-Plate®,	ARI)	using	a	Gryphon	robot,	at	a	protein:reservoir	ratio	of	1:1	and	1:2.	When	required	hits	were	optimized	by	hanging-drop	vapor	diffusion	technique.	30	%	(v/v)	ethylene	glycol	 was	 used	 as	 cryoprotectant	 to	 harvest	 and	 cool	 flash	 crystals	 in	 liquid	nitrogen.	Listed	below	(Table	4.1)	are	the	crystallization	conditions	that	gave	the	crystals	used	for	data	collection.				
Table	4.1.	Omp35	and	Omp36	crystallization	conditions.	Omp35	 0.05 M Magnesium sulfate, 8% (w/v) PEG 8000	Omp36	 0.1 M Tris-HCl pH 8.5, 8% (w/v) PEG 8000		
4.2.4	Omp35	and	Omp36	data	collection	and	structure	determination	
	A	data	set	of	both	Omp35	and	Omp36	was	collected	at	the	Diamond	Synchrotron	Light	 Source	 (UK),	 beam-line	 i02,	 i04	 respectively.	 Data	 were	 processed	 using	Mosflm	 [237]	 and	 scaled	with	 SCALA.	The	 structures	were	 solved	by	molecular	replacement	 [187]	 to	 a	 resolution	 of	 2.85	 Å	 (Omp35)	 and	 2.45	 Å	 (Omp36).	OmpK36	 (ID	PDB:	 1OSM)	was	 used	 as	 search	model	 to	 solve	Omp36	 structure,	while	 OmpF	 (ID	 PDB:	 2OMF)	 was	 used	 as	 search	 model	 to	 solve	 Omp35.	 The	
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structures	 were	 built	 manually	 using	 Coot	 [188]	 and	 refined	 using	 REFMAC5	[189].	Data	quality	was	checked	by	Molprobity	[238].		
4.2.5	Liposome	swelling	assay	
	OmpC	 and	OmpF	porins	 used	 for	 the	 liposome	 swelling	 assay	were	 purified	 by	our	 collaborators	 from	 the	 Jacobs	 University	 in	 Bremen	 (Grermany).	 Liposome	swelling	 assay	 data	 on	 OmpE35/36	 and	 OmpK35/36	 were	 obtained	 by	 our	collaborators	from	Newcastle	University	(UK).			Liposome	 swelling	 assay	was	 carried	 out	 following	 the	 procedure	 described	 by	Nikaido	[239]	(Figure	4.1).	Liposome	vesicles	were	prepared	by	mixing	100	mg	of	dihexacetyl	phosphate	dissolved	in	0.5	ml	of	CHCl3	and	2	ml	of	L-α-phosphatidyl	choline	(both	Sigma).	250	μl	of	the	mixture	was	dried	under	vacuum	for	2	hours.	300	μl	 of	 distilled	water	was	 added	 to	 the	dried	 liposomes	 along	with	30	μg	of	either	 Omp35,	 Omp36,	 OmpC,	 or	 OmpF.	 The	 solution	 was	 then	 sonicated	 in	 a	Branson	bath-type	sonicator	for	one	minute.	The	resulting	mixture	was	left	drying	under	vacuum	overnight.	For	the	blank	control,	the	protein	was	substituted	with	buffer.	Dried	proteoliposomes	were	resupended	in	12	mM	stackyose	dissolved	in	10	mM	Hepes	pH	7.	The	mixture	was	left	at	room	temperature	(RT)	for	two	hours	before	 starting	 the	 experiments.	 Consecutively,	 5-10	 μl	 of	 the	 liposome	 was	quickly	 mixed	 with	 200	 μl	 of	 an	 isotonic	 solution	 containing	 the	 substrates	(nutrient	or	antibiotic)	to	be	tested.	The	concentration	of	the	substrate/antibiotic	ranged	 between	 8-20	 mM	 (see	 Table	 4.3).	 The	 correct	 concentration	 was	
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determined	by	detecting	 the	concentration	at	which	 the	blank	did	not	 show	(or	showed	 less	 that	5%)	any	variation	of	optical	density	at	400	nm.	Permeation	of	the	 tested	 antibiotics	 through	 the	 porins	 was	 assayed	 by	 determining	 the	variation	of	optical	density	at	400	nm.	Readings	were	taken	every	5	seconds	for	one	minute.	Measurements	 from	 the	 same	 set	 of	 proteoliposome	were	 taken	 in	triplicate.			
	
	


















































































	Omp35	 and	 Omp36	 crystals	 appeared	 within	 a	 week.	When	 necessary	 crystals	were	optimized	by	hanging	drop	vapor	technique	(final	crystallization	conditions	for	 each	 protein	 are	 listed	 in	 4.1)	 (Figure	 4.3).	 Crystals	were	 cryo-protected	 in	ethylene	glycol	and	analyzed	by	synchrotron	radiation	at	Diamond	Light	Source,	beam	 line	 iO2,	 iO4-1	 for	Omp35	 and	Omp36,	 respectively.	Omp35	data	 set	was	processed	 to	 a	 resolution	 of	 2.85	 Å	 in	 the	 space	 group	 I222	 and	 solved	 by	molecular	 replacement	 using	 OmpF	 (PDB	 code:	 1OMF)	 as	 the	 search	 model.	Omp36	data	set	was	processed	to	a	resolution	of	2.47	Å	in	the	space	group	P3	and	solved	by	molecular	replacement	using	OmpK36	(PDB	code:)	as	the	search	model.	Analysis	of	Mathew’s	coefficient	(Mathew’s	coefficient:	2.19	and	2.32	for	Omp35	and	 Omp36,	 respectively)	 showed	 a	 trimeric	 arrangement	 in	 the	 cell	 unit.	 For	both	structures,	the	quality	of	the	structures	was	assessed	using	Molprobity.	Data	collection	and	refinement	statistics	are	shown	in	table	4.2.	
	










Rfactor/Rfree	(%)	 21.33/26.0	 19.5/23.9	N°	of	unique	reflections	 33222	 74780	N°	of	residues	 337	 335	Water	 -	 98		
















Figure	4.4:	Sequence	alignment	of	Omp35	and	Omp36.	Conserved	negatively	charged	amino	 acids	 in	 L3	 are	 indicated	 with	 red	 triangles.	 Positively	 charged	 amino	 acids,	opposite	the	L3,	are	indicated	with	blue	arrows.	L4	and	L5	are	boxed	in	black.	
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Glycine	 (+,-)	 75	 17	
Arginine	 (+,+,-)	 174	 17	
Glutamate	 (+,-,-)	 146	 12	
Glucose	 (0)	 180	 12	
Penicillins	 	
Ampicillin	 (+,-)	 349	 12	
Ticarcillin	 (-,-)	 382	 10	
Piperacillin	 (-)	 517	 10	
Carbapenems	 	
Ertapenem	 (+,-,-)	 475	 15	
Imipenem	 (+,-)	 299	 12	
Meropenem	 (+,-)	 383	 12	
Cephalosphorins	 	
Cefotaxime	 (-)	 454	 12	
Cefepime	 (+,-)	 481	 8	

































































































	In	 this	 study,	 we	 present	 the	 X-ray	 structures	 of	 the	 two	major	 porins	 from	E.	
aerogenes,	Omp35	 and	 Omp36.	 The	 structures	 we	 obtained,	 showed	 a	 trimeric	arrangement,	 as	 already	 indicated	 from	 the	 SEC	 profile.	 Overall,	 the	 structural	features	 observed	 in	 Omp35	 and	Omp36	 are	 common	 to	 all	 the	 general	 porins	characterized	 so	 far	 in	 the	Enterobacteriaceae	 family.	 A	 barrel	 consisting	 of	 16	anti-parallel	 β-strands	 linked	 together	 by	 long	 extracellular	 loops	 (L1-L7)	 and	short	periplasmic	turns	(T1-T7).	The	constriction	zone	of	the	pore	encloses	highly	conserved	residues	whereas	the	external	loops	are	different.		.	
4.4.2	Structural	comparison	of	OmpC-like	and	OmpF-like	porins	in	
Enterobacteriaceae		




		In	both	OmpC-like	and	OmpF-like,	a	strong	transverse	electric	 field	 is	generated	by	the	separation	of	charged	residues	on	opposite	sides	of	the	constriction	zone.	The	acidic	residues	from	the	eyelet	of	OmpF	(D113,	E117,	D121),	are	conserved	in	all	structures,	however	some	differences	are	found	at	the	level	of	the	arginine	and	lysine	 cluster.	 From	 the	 top	 of	 such	 cluster,	 R167	 is	 conserved	 in	 Omp35	 and	OmpK35	 while	 it	 is	 replaced	 in	 others	 by	 an	 uncharged	 amino	 acid:	 L167	 in	OmpC,	 OmpE35	 and	 OmpE36,	 Q167	 in	 Omp36	 and	 S167	 in	 OmpK36.	 The	positively	charged	residues	from	the	basic	ladder	inside	the	CR	are	conserved	in	all	OmpF-like	structures	but	K80	that	is	replaced	by	a	tryptophan	(W80)	in	OmpC,	and	all	OmpC-like	porins	(Omp36,	OmpE36	and	OmpK36).	
	
	





























E.	aerogenes	porins.	Zwetterionic	antibiotics	showed	a	higher	rate	of	permeation	compared	 to	 negatively	 charged	 antibiotics.	 As	 expected	 from	 is	 larger	 pore,	Omp35	has	higher	permeability	than	Omp36.			We	 also	 analyzed	 permeations	 of	 the	 above-mentioned	 antibiotics	 through	 the	OmpC-like	and	OmpF-like	porins.	Once	again	as	might	be	expected	from	the	pore	sizes	 the	 antibiotics	 have	 a	 higher	permeability	 through	OmpF	and	orthologues	Omp35,	 OmpE35,	 OmpK35	 than	 OmpC	 and	 orthologues	 Omp36,	 OmpE36,	OmpK36.	 The	 liposome	 swelling	 assay	 results	 for	 OmpF	 permeability	 are	 in	agreement	 with	 previous	 liposome	 swelling	 assay	 data	 and	 with	 influx	 rate	measurements	in	intact	cells.		The	 zwitterionic	molecules	meropenem,	 imipenem	and	 cefepime	 exhibited	high	relative	 permeability	 through	 all	 porins.	 Interestingly,	 ampicillin,	 had	 lower	relative	permeability,	resembling	more	the	negatively	charged	molecules	such	as	ceftazidime,	 cefotaxime,	 piperacillin	 and	 ticarcillin	 which	 displayed	 very	 low	permeabilities	 In	 contrast,	 ertapenem,	 which	 has	 a	 net	 negative	 charge	 shows	elevated	 permeability,	 similar	 to	 that	 of	 zwitterionic	 molecules,	 except	 via	OmpE35	and	OmpE36,	the	only	species	specific	effect	that	was	detected.	Overall,	meropenem	 showed	 the	 highest	 porin	 permeability	 while	 piperacillin	 and	ticarcillin	had	the	lowest.			
Chapter	4:	Omp35	and	Omp36	from	Enterobacter	aerogenes	
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	In	 this	 study	 we	 presented	 the	 X-ray	 structures	 of	 the	 two	 major	 porins	 in	 E.	
aerogenes,	Omp35	and	Omp36.	Sequence	and	structural	alignment	of	Omp35/36	with	their	orthologs	in	E.	cloacae	(OmpE35/36)	K.	pneumonia	(OmpK35/36)	and	















In	this	work,	we	have	presented	the	structural	and	functional	analysis	performed	on	MOMP	 and	Omp50	 from	C.	 jejuni	 and	Omp35	 and	Omp36	 from	E.	aerogenes.	Both	bacteria	are	pathogenic	for	humans,	causing	gastrointestinal	and	respiratory	infections,	respectively.		MOMP	was	expressed	in	the	native	C.	jejuni	and	its	x-ray	structure	was	solved.	The	structure	showed	that	MOMP	was	a	trimeric	porin	of	18	β-strand	monomers.	The	obtained	structure	was	compared	to	the	structure	of	the	recombinantly	expressed	MOMP,	and	despite	differences	in	the	LPS	composition	between	E.	coli	and	C.	jejuni,	we	found	the	two	structures	to	be	identical.	We	then	focused	our	attention	on	the	calcium	binding	site	 found	at	 the	constriction	zone.	Electrophysiology	analysis	of	MOMP	behavior	in	the	presence	and	absence	of	calcium	led	us	to	conclude	that	the	metal	 ion	 is	 important	 for	 the	 stability	 of	 the	 structure,	 as	 it	 holds	 together	 a	number	of	key	loops	(L3,	L4	and	L6)	involved	in	its	binding.	Furthermore,	in	silico	data	obtained	in	collaboration	with	the	University	of	Cagliari	gave	us	some	insight	on	 the	 functional	 role	 of	 the	 calcium,	 specifically,	 highlighting	 the	 effect	 of	 the	calcium	on	the	ciprofloxacin	permeation.				It	 is	well	 established	 that	 the	 constriction	 zone	 of	 porins	 plays	 a	 crucial	 role	 in	substrates	permeation	and	thus	any	alterations	at	 this	 level	can	 lead	to	 impaired	diffusions	 [243].	 In	MOMP,	 the	 presence	 of	 the	 calcium	 neutralizes	 the	 negative	charges	of	the	residues	D155,	D120	and	E288	in	the	eyelet,	weakening	the	electric	field	 and	 increasing	 the	 energy	 barrier	 for	 translocation.	 Following	 these	
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observations,	 it	 would	 be	 useful	 to	 test	 several	 antibiotics,	 using	 for	 example	liposome	 swelling	 assay,	 and	 to	 analyze	 their	 permeation	 rate	with	 and	without	calcium.	 This	 would	 provide	 us	 with	 more	 data	 on	 how	 the	 calcium	 effects	 the	translocation	of	different	classes	of	antibiotics	and	thus	improve	the	design	of	new	ones.			Omp50,	also	a	porin	from	C.	jejuni,	was	also	the	object	of	study	in	this	work.		Omp50	purification	was	first	attempted	in	the	native	Campylobacter,	but	due	to	the	low	 expression	 level	 and	 low	 purity	 we	 decided	 to	 use	 a	 recombinant	 system.	Omp50	was	successfully	expressed	 in	E.	coli	 and	 the	purified	porin	showed	pore	activity,	 when	 inserted	 in	 a	 lipid	 bilayer	 comparable	 to	 the	 protein	 natively	expressed.	 Crystallization	 of	 Omp50	was,	 however,	 hard	 to	 achieve.	 Omp50	was	also	tested	 in	order	to	 find	evidences	of	 its	proposed	kinase	activity.	None	of	 the	experiments	 we	 performed,	 with	 either	 the	 recombinant	 or	 the	 native	 protein,	suggested	 that	Omp50	 is	able	 to	auto-phosphorylize	or	 is	able	 to	hydrolyze	ATP.	Hence,	 our	 data	 are	 in	 disagreement	with	 that	 proposed	 by	 Corcionivoschi	 et	al	[207].						
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Lastly,	 we	 determined	 the	 X-ray	 structures	 of	 Omp35	 and	 Omp36	 from	 E.	
aerogenes,	orthologues	of	the	E.	coli	OmpF	and	OmpC,	respectively.	The	structures	we	 obtained	 showed	 that	 both	 Omp35	 and	 Omp36	 were	 homotrimer	 of	 16	 β-strands	 monomers.	 Omp35	 and	 Omp36	 structures	 also	 showed	 high	 levels	 of	homology	 with	 OmpC	 and	 OmpF	 from	 E.	 coli,	 OmpE35/36	 from	 E.	 cloacae	 and	Ompk35/36	from	K.	pneumonie.		




E.	 aerogenes	 strains	 isolated	 from	 hospitalized	 patients	 have	 been	 shown	 to	 be	resistant	 to	 a	 wide	 range	 of	 antibiotics	 [220].	 Omp35	 and	 Omp36,	 E.	 aerogenes	major	 porins,	 play	 an	 important	 role	 in	 the	 multi-drug	 resistance	 phenomenon	[235].	Variation	in	their	expression	of	these	two	porins	and	mutation	at	the	level	of	the	constriction	zone	are	the	main	mechanisms	that	lead	to	antibiotic	resistance	in	
E.	aerogenes	 [235],	 [236].	The	structural	and	 functional	analysis	we	presented	 in	this	work	 represent,	 a	 good	 starting	 point	 to	 better	 understand	 translocation	 of	antibiotics	through	porins	of	pathogenic	bacteria.	In	order	to	investigate	how	(and	to	 what	 extent)	 these	 mutations	 impair	 the	 permeation	 of	 different	 classes	 of	antibiotics	when	compared	to	the	wild-type,	such	analysis	could	also	be	extended	to	 Omp35	 and	 Omp36	 (and	 also	 their	 orthologues)	 that	 carry	 mutations	 at	 the	level	of	the	constriction	zone.	
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	Auto	–Induction	medium	(1L)	 ZY	 (10	 g	 N-Z-amine,	 5	 g	 yeast	 extract)	 media	supplemented	with	1mM	MgSO4,	0.5%	glycerol,	0.05%	glucose,	0.2%	lactose,	25	mM	(NH4)2SO4,	50	mM	KH2PO4,	50mM	Na2HPO4	LB	(1L)	 10	g	tryptone,	5	g	yeast	extract,	10	g	NaCl	TB	(1L)	 12	g	tryptone,	24	g	yeast	extract,	4	mL	glycerol	TPB	(1L)	 20	 g	 tryptose,	 2	 g	 dextrose,	 5	 g	 NaCl,	 2.5	 g	Na2PO4		Lysis	buffer	 50	 mM	 Sodium	 phosphate	 pH	 7.4,	 250	 mM	NaCl,	10	%	glycerol		Extraction	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	mM	β-mercaptoethanol,	7%	OPOE	Wash	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 50	 mM	 imidazole,	1%	OPOE	Elution	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 250	 mM	 imidazole,	1%	OPOE	Dialysis	buffer	 10	mM	Tris-HCl	pH	8,	 250	mM	NaCl,	 2	mM	β-mercaptoethanol,	10%	glycerol,	1%	OPOE	
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SEC	buffer	 10	 mM	 Tris-HCl	 pH	 8,	 150	 mM	 NaCl,	 0.45	 %	(v/v)	C8E4	IB	buffer	 20	mM	Hepes	pH7,	300	mM	NaCl	Refolding	buffer	 50	mM	sodium	phosphate,	 250	NaCl,	 2	mM	β-mercaptoethanol	 (supplemented	 with	 chosen	detergents)	Proteolytic	enzymes	buffers		Α-Chymotrypsin	 1	mM	HCl,	2	mM	CaCl2	Trypsine	 1	mM	HCl,	2	mM	CaCl2	Papain	 H2O	Subtilisin	A	 10	mM	NaOAc	Western	blot	buffers		Anode	buffer	1	 300	mM	Trizma	base,	20%	methanol	Anode	buffer	2	 25	mM	Trizma	base,	20%	methanol	Cathode	buffer	 5.2	 g	 amino	 capronic	 acid,	 20%	 methanol,	0.01%	SDS	
A3.	Omp35/36	LB	(1L)	 10	g	tryptone,	5	g	yeast	extract,	10g	NaCl	Lysis	buffer	 50	 mM	 Sodium	 phosphate	 pH	 7.4,	 250	 mM	NaCl,	10	%	glycerol		Extraction	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	mM	β-mercaptoethanol,	7%	OPOE	
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Wash	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 50	 mM	 imidazole,	1%	OPOE	Elution	buffer	 50	mM	sodium	phosphate	pH	8,	250	mM	NaCl,	5	 mM	 β-mercaptoethanol,	 250	 mM	 imidazole,	1%	OPOE	Dialysis	buffer	 10	mM	Tris-HCl	pH	8,	 250	mM	NaCl,	 2	mM	β-mercaptoethanol,	10%	glycerol,	1%	OPOE	SEC	buffer	 10	 mM	 Tris-HCl	 pH	 8,	 150	 mM	 NaCl,	 0.45	 %	(v/v)	C8E4															
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B.	Crystallization	screenings	















	 Protein	name	 PDB	code	OmpC	 2j1n	LamB	 1MAL	OccD1	 4FOZ	CymA	 4D5B	OmpG	 2F1C	FhuA	 2GRX	SusCD	 2FQ6	OmpT	 1I78	OMPLA	 1QD6	BamA	 4K3B	BamB	 4XGA	MOMP	 5LDT(native),	5LDV(rec)	Omp35	 5O78	(to	be	published)	Omp36	 5O9C	(to	be	published)								
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D.	Publication	s	
